
<html lang="en"     class="pb-page"  data-request-id="fa9a199c-d0b7-4610-92ef-ff8da8340670"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-3;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b00982;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists" /></meta><meta name="dc.Creator" content="Jun  Shi" /></meta><meta name="dc.Creator" content="Zhengxiang  Gu" /></meta><meta name="dc.Creator" content="Elizabeth Anne  Jurica" /></meta><meta name="dc.Creator" content="Ximao  Wu" /></meta><meta name="dc.Creator" content="Lauren E.  Haque" /></meta><meta name="dc.Creator" content="Kristin N.  Williams" /></meta><meta name="dc.Creator" content="Andres S.  Hernandez" /></meta><meta name="dc.Creator" content="Zhenqiu  Hong" /></meta><meta name="dc.Creator" content="Qi  Gao" /></meta><meta name="dc.Creator" content="Marta  Dabros" /></meta><meta name="dc.Creator" content="Akin H.  Davulcu" /></meta><meta name="dc.Creator" content="Arvind  Mathur" /></meta><meta name="dc.Creator" content="Richard A.  Rampulla" /></meta><meta name="dc.Creator" content="Arun Kumar  Gupta" /></meta><meta name="dc.Creator" content="Ramya  Jayaram" /></meta><meta name="dc.Creator" content="Atsu  Apedo" /></meta><meta name="dc.Creator" content="Douglas B.  Moore" /></meta><meta name="dc.Creator" content="Heng  Liu" /></meta><meta name="dc.Creator" content="Lori K.  Kunselman" /></meta><meta name="dc.Creator" content="Edward J.  Brady" /></meta><meta name="dc.Creator" content="Jason J.  Wilkes" /></meta><meta name="dc.Creator" content="Bradley A.  Zinker" /></meta><meta name="dc.Creator" content="Hong  Cai" /></meta><meta name="dc.Creator" content="Yue-Zhong  Shu" /></meta><meta name="dc.Creator" content="Qin  Sun" /></meta><meta name="dc.Creator" content="Elizabeth A.  Dierks" /></meta><meta name="dc.Creator" content="Kimberly A.  Foster" /></meta><meta name="dc.Creator" content="Carrie  Xu" /></meta><meta name="dc.Creator" content="Tao  Wang" /></meta><meta name="dc.Creator" content="Reshma  Panemangalore" /></meta><meta name="dc.Creator" content="Mary Ellen  Cvijic" /></meta><meta name="dc.Creator" content="Chunshan  Xie" /></meta><meta name="dc.Creator" content="Gary G.  Cao" /></meta><meta name="dc.Creator" content="Min  Zhou" /></meta><meta name="dc.Creator" content="John  Krupinski" /></meta><meta name="dc.Creator" content="Jean M.  Whaley" /></meta><meta name="dc.Creator" content="Jeffrey A.  Robl" /></meta><meta name="dc.Creator" content="William R.  Ewing" /></meta><meta name="dc.Creator" content="Bruce Alan  Ellsworth" /></meta><meta name="dc.Description" content="G protein-coupled receptor 40 (GPR40) has become an attractive target for the treatment of diabetes since it was shown clinically to promote glucose-stimulated insulin secretion. Herein, we report ..." /></meta><meta name="Description" content="G protein-coupled receptor 40 (GPR40) has become an attractive target for the treatment of diabetes since it was shown clinically to promote glucose-stimulated insulin secretion. Herein, we report ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 27, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00982" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00982" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00982" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00982" /></link>
        
    
    

<title>Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00982" /></meta><meta property="og:title" content="Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0011.jpeg" /></meta><meta property="og:description" content="G protein-coupled receptor 40 (GPR40) has become an attractive target for the treatment of diabetes since it was shown clinically to promote glucose-stimulated insulin secretion. Herein, we report our efforts to develop highly selective and potent GPR40 agonists with a dual mechanism of action, promoting both glucose-dependent insulin and incretin secretion. Employing strategies to increase polarity and the ratio of sp3/sp2 character of the chemotype, we identified BMS-986118 (compound 4), which showed potent and selective GPR40 agonist activity in vitro. In vivo, compound 4 demonstrated insulinotropic efficacy and GLP-1 secretory effects resulting in improved glucose control in acute animal models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00982"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00982">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00982&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00982&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00982&amp;href=/doi/10.1021/acs.jmedchem.7b00982" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 681-694</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00530" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01051" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Shi">Jun Shi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0810-3368" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhengxiang++Gu">Zhengxiang Gu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+Anne++Jurica">Elizabeth Anne Jurica</a></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3689-5451" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ximao++Wu">Ximao Wu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lauren+E.++Haque">Lauren E. Haque</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristin+N.++Williams">Kristin N. Williams</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andres+S.++Hernandez">Andres S. Hernandez</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhenqiu++Hong">Zhenqiu Hong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Gao">Qi Gao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marta++Dabros">Marta Dabros</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Akin+H.++Davulcu">Akin H. Davulcu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arvind++Mathur">Arvind Mathur</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+A.++Rampulla">Richard A. Rampulla</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arun+Kumar++Gupta">Arun Kumar Gupta</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramya++Jayaram">Ramya Jayaram</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atsu++Apedo">Atsu Apedo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+B.++Moore">Douglas B. Moore</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heng++Liu">Heng Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lori+K.++Kunselman">Lori K. Kunselman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+J.++Brady">Edward J. Brady</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason+J.++Wilkes">Jason J. Wilkes</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bradley+A.++Zinker">Bradley A. Zinker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Cai">Hong Cai</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yue-Zhong++Shu">Yue-Zhong Shu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qin++Sun">Qin Sun</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+A.++Dierks">Elizabeth A. Dierks</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly+A.++Foster">Kimberly A. Foster</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carrie++Xu">Carrie Xu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Wang">Tao Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reshma++Panemangalore">Reshma Panemangalore</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Ellen++Cvijic">Mary Ellen Cvijic</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chunshan++Xie">Chunshan Xie</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary+G.++Cao">Gary G. Cao</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++Zhou">Min Zhou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Krupinski">John Krupinski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean+M.++Whaley">Jean M. Whaley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+A.++Robl">Jeffrey A. Robl</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+R.++Ewing">William R. Ewing</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+Alan++Ellsworth">Bruce Alan Ellsworth</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="AFF-d94e358-autogenerated"><span class="aff-text">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1-609-466-5075. E-mail: <a href="/cdn-cgi/l/email-protection#e9839c87c79a8180a98b849ac78a8684"><span class="__cf_email__" data-cfemail="ed879883c39e8584ad8f809ec38e8280">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00982&amp;href=/doi/10.1021%2Facs.jmedchem.7b00982" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 681–694</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 9, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 July 2017</li><li><span class="item_label"><b>Published</b> online</span>27 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 February 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00982" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00982</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D681%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJun%2BShi%252C%2BZhengxiang%2BGu%252C%2BElizabeth%2BAnne%2BJurica%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D3%26contentID%3Dacs.jmedchem.7b00982%26title%3DDiscovery%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BDihydropyrazole%2BGPR40%2BAgonists%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D694%26publicationDate%3DFebruary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00982"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3507</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00982" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Zhengxiang&quot;,&quot;last_name&quot;:&quot;Gu&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Anne Jurica&quot;},{&quot;first_name&quot;:&quot;Ximao&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Lauren&quot;,&quot;last_name&quot;:&quot;E. Haque&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;N. Williams&quot;},{&quot;first_name&quot;:&quot;Andres&quot;,&quot;last_name&quot;:&quot;S. Hernandez&quot;},{&quot;first_name&quot;:&quot;Zhenqiu&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Marta&quot;,&quot;last_name&quot;:&quot;Dabros&quot;},{&quot;first_name&quot;:&quot;Akin&quot;,&quot;last_name&quot;:&quot;H. Davulcu&quot;},{&quot;first_name&quot;:&quot;Arvind&quot;,&quot;last_name&quot;:&quot;Mathur&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;A. Rampulla&quot;},{&quot;first_name&quot;:&quot;Arun&quot;,&quot;last_name&quot;:&quot;Kumar Gupta&quot;},{&quot;first_name&quot;:&quot;Ramya&quot;,&quot;last_name&quot;:&quot;Jayaram&quot;},{&quot;first_name&quot;:&quot;Atsu&quot;,&quot;last_name&quot;:&quot;Apedo&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;B. Moore&quot;},{&quot;first_name&quot;:&quot;Heng&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Lori&quot;,&quot;last_name&quot;:&quot;K. Kunselman&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;J. Brady&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;J. Wilkes&quot;},{&quot;first_name&quot;:&quot;Bradley&quot;,&quot;last_name&quot;:&quot;A. Zinker&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;Yue-Zhong&quot;,&quot;last_name&quot;:&quot;Shu&quot;},{&quot;first_name&quot;:&quot;Qin&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;A. Dierks&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;A. Foster&quot;},{&quot;first_name&quot;:&quot;Carrie&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Reshma&quot;,&quot;last_name&quot;:&quot;Panemangalore&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Ellen Cvijic&quot;},{&quot;first_name&quot;:&quot;Chunshan&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;G. Cao&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Krupinski&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;M. Whaley&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;A. Robl&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;R. Ewing&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;Alan Ellsworth&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;681-694&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00982&quot;},&quot;abstract&quot;:&quot;G protein-coupled receptor 40 (GPR40) has become an attractive target for the treatment of diabetes since it was shown clinically to promote glucose-stimulated insulin secretion. Herein, we report our efforts to develop highly selective and potent GPR40 agonists with a dual mechanism of action, promoting both glucose-dependent insulin and incretin secretion. Employing strategies to increase polarity and the ratio of sp3/sp2 character of the chemotype, we identified BMS-986118 (compound 4), which showed potent and selective GPR40 agonist activity in vitro. In vivo, compound 4 demonstrated insulinotropic efficacy and GLP-1 secretory effects resulting in improved glucose control in acute animal models.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00982&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00982" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00982&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00982" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00982&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00982" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00982&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00982&amp;href=/doi/10.1021/acs.jmedchem.7b00982" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00982" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00982" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00982%26sid%3Dliteratum%253Aachs%26pmid%3D29316397%26genre%3Darticle%26aulast%3DShi%26date%3D2018%26atitle%3DDiscovery%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BDihydropyrazole%2BGPR40%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D3%26spage%3D681%26epage%3D694%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/jmcmar.2018.61.issue-3/20180208/jmcmar.2018.61.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">G protein-coupled receptor 40 (GPR40) has become an attractive target for the treatment of diabetes since it was shown clinically to promote glucose-stimulated insulin secretion. Herein, we report our efforts to develop highly selective and potent GPR40 agonists with a dual mechanism of action, promoting both glucose-dependent insulin and incretin secretion. Employing strategies to increase polarity and the ratio of sp<sup>3</sup>/sp<sup>2</sup> character of the chemotype, we identified BMS-986118 (compound <b>4</b>), which showed potent and selective GPR40 agonist activity <i>in vitro</i>. <i>In vivo</i>, compound <b>4</b> demonstrated insulinotropic efficacy and GLP-1 secretory effects resulting in improved glucose control in acute animal models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Type 2 diabetes, representing over 85% of diabetes cases, is a progressive disease characterized by insulin resistance resulting in insufficient insulin action, eventually leading to a loss of glucose homeostasis. The rapidly growing prevalence of type 2 diabetes mellitus (T2DM) is a worldwide health concern due to its contribution toward cardiovascular co-morbidities (e.g., heart failure, stroke) and microvascular damage leading to blindness, kidney failure, foot ulcers, neuropathic pain, and more.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> According to the World Health Organization (WHO), over 300 million people worldwide were estimated to have diabetes in 2013,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and that number is projected to rise to 629 million by 2045.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Metformin is the first-line treatment of type 2 diabetes.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Other glucose-independent therapies for the treatment of diabetes include insulin secretagogues, such as sulfonylureas (lowering HbA1c by ∼1.5%) and glinides (HbA1c lowering by ∼1.5%).<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> While effective in the short term, chronic use of these treatments can lead to hypoglycemia and β-cell exhaustion. These limitations often lead to disease progression, resulting in the need for polypharmacology or transition to insulin therapies.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> As an alternative mechanism to treat diabetes, incretin-based therapies are appealing due to their ability to stimulate insulin in a glucose-dependent fashion (glucose-stimulated insulin secretion, GSIS). DPP4 inhibitors and GLP-1 mimetics are among these treatment options, and they are effective at lowering HbA1c with the benefit of a reduced risk for hypoglycemia.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> There remains potential opportunity for additional incretin-based therapies, since DPP4 inhibition exhibits modest HbA1c lowering (∼0.7%) and GLP-1 mimetics can have some safety/tolerability limitations.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Peroxisome proliferator-activated receptor γ (PPARγ) agonists increase insulin sensitivity and infrequently result in hypoglycemia but concerns around their side effects (significant weight gain, and possible cardiovascular and bladder cancer risks) have limited their clinical use.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> A promising new class of treatments for diabetes, SGLT-2 inhibitors, demonstrates insulin-independent glucose lowering while providing additional benefits such as moderate weight loss and blood-pressure lowering; however, modest efficacy (lowering HbA1c ∼0.5–0.9%) leaves opportunity for other therapies that further reduce HbA1c without risk of hypoglycemia. Lastly, many patients progress to the use of injected insulin, which is an effective therapy to manage T2DM, but it must be carefully titrated to avoid incidence of hypoglycemia and weight gain.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">G protein-coupled receptor 40 (GPR40), also known as free fatty acid receptor 1 (FFAR1), is a G<sub>q</sub> protein-coupled receptor (GPCR) that is predominately expressed in pancreatic β-cells and is also found in the GI tract and brain.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> GPR40 is activated by free fatty acids (FFAs) such as docosahexaenoic acid (DHA) and linoleic acid (LA). In pancreatic β-cells, glucose metabolism induces the closure of ATP-sensitive K<sup>+</sup> channels in the plasma membrane, which reduces K<sup>+</sup> efflux and depolarizes the membrane, opening Ca<sup>2+</sup> channels. Activation of GPR40 causes increases in intracellular Ca<sup>2+</sup> concentrations via the inositol 1,4,5-trisphosphate (IP<sub>3</sub>) pathway, and increased Ca<sup>2+</sup> stores leads to amplified insulin release after the glucose-induced membrane depolarization.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Since the insulinotropic effect is glucose-dependent, GPR40 agonists have the therapeutic potential to treat diabetes with a low risk of hypoglycemia. In addition, GPR40-null mutant mice exhibit reduced GLP-1 and glucose-dependent insulintropic peptide (GIP) secretion suggesting that GPR40 may be involved in FFA-mediated incretin secretion.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Several GPR40 agonists have been reported to stimulate both GLP-1 and GIP secretion <i>in vivo</i>, providing a second mechanism to control GSIS.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> The constellation of GPR40-mediated effects makes it an attractive target for the treatment of type-2 diabetes.</div><div class="NLM_p">Recently, we disclosed potent GPR40 agonists <b>1</b> and <b>2</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), featuring a pyrrolidine ring and a dihydropyrazole ring, respectively.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> GPR40 is a receptor that binds long-chain fatty acids, and we found that ligands with 4 rings (A–D, as depicted in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> structures <b>1</b> and <b>2</b>) yielded optimal agonist activity. Both compounds exhibited potent GPR40 agonist activity and glucose-lowering efficacy in several animal models of diabetes, however, each demonstrated <i>in vivo</i> off-target liabilities that precluded their advancement: compound <b>1</b> caused hyperactivity in rats and compound <b>2</b> induced undesired blood-pressure and heart rate increases in rodents and monkeys at high doses.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Both compounds also demonstrated PPARγ activity <i>in vitro</i>. It is known that PPARγ agonists improve insulin sensitization and this activity may provide additional therapeutic benefit in combination with GPR40 agonists. However, since PPARγ agonism may introduce increased safety risks, and the safety profile of GPR40 agonists has not been fully de-risked in clinical development, we decided that it would be prudent to develop a GPR40 selective agonist that was devoid of PPARγ activity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The undesired hyperactive and cardiovascular effects of compounds <b>1</b> and <b>2</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> also caused concern for advancement of these compounds, especially in a population that is prone to cardiovascular (CV) disease.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> We found that the CV liabilities of <b>2</b> were due to off-target pharmacology since hemodynamic changes were observed when compound <b>2</b> was administered to GPR40 knockout mice.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Despite extensive <i>in vitro</i> profiling efforts, we were unable to identify the origin of the undesired CV effects.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The rather high log P and associated lipophilicity of these compounds may have contributed to the promiscuity of their actions <i>in vivo</i>. We therefore adopted a strategy to reduce log P and fractional aromaticity of the ligands, believing that this approach would lead to compounds that matched the spatial/electronic requirements for GPR40 agonism while being less likely to match those of any unidentified targets.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of dihydropyrazole and pyrrolidine GPR40 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein, we describe the identification of a series of pyrrolidine and dihydropyrazole derivatives leading to compound <b>4</b>, a novel GPR40 agonist with an improved potency, pharmacokinetics, glucose-lowering efficacy, and safety profile.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of dihydropyrazole analogues is detailed in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The preparation of dihydropyrazole phenol intermediate <b>14</b> began with acylation of hydrazine <b>5</b> with TFAA to afford hydrazide <b>6</b>. Treatment of <b>6</b> with benzenesulfonyl chloride and DIEA afforded a hydrazonoyl chloride that was subjected to a [3+2] cycloaddition with alkene <b>7</b> providing dihydropyrazole <b>8</b> with 2:1 diastereoselectivity (the stereochemistry of <b>8</b> was confirmed by X-ray analysis).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Intermediate <b>8</b> was homologated to ester <b>12</b> by a four-step sequence. First, intermediate <b>8</b> was reduced with NaBH<sub>4</sub> in THF and H<sub>2</sub>O to give alcohol <b>9</b>. The resulting alcohol was converted to mesylate <b>10</b> via reaction with MsCl and Et<sub>3</sub>N in DCM at room temperature. Displacement of <b>10</b> via treatment with potassium cyanide in DMSO at 40 °C generated nitrile <b>11</b> that was subsequently hydrolyzed to the corresponding methyl ester <b>12</b> using 3.6 M HCl in MeOH at room temperature. Miyaura borylation<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> of <b>12</b> afforded boronate <b>13</b> that was subjected to peroxide-mediated (H<sub>2</sub>O<sub>2</sub>) oxidation to produce key intermediate, phenol <b>14</b>. Synthesis of D-ring analogues (see <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> for ring nomenclature) was accomplished via coupling between 4-hydroxyl piperidine <b>15</b> and various aryl bromides using first-generation S-Phos precatalyst and LiHMDS in THF at 60 °C. Tosylation of alcohols <b>16a–ac</b> with TsCl and pyridine afforded the corresponding tosylates <b>17a–ac</b>. Displacement of the tosyl group with dihydropyrazole phenol <b>14</b> under basic conditions generated substituted methyl esters <b>18a–ac</b>. Finally, hydrolysis of esters <b>18a–ac</b> furnished the desired dihydropyrazole analogues <b>3a</b> and <b>19a–ac</b> with different aromatic/heteroaromatic D-rings.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Dihydropyrazole D-Ring Analogues: (A) Synthesis of Dihydropyrazole A–B Ring and (B) Synthesis of D-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TFAA, DCM, 0 °C to rt, 81%; (b) benzenesulfonyl chloride, DIEA, DCM, 0 °C to rt, 90%; (c) Ag<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 65 °C, 46%; (d) NaBH<sub>4</sub>, THF/H<sub>2</sub>O, rt, 94%; (e) MsCl, Et<sub>3</sub>N, DCM, rt, 98%; (f) KCN, DMSO, 40 °C, 92%; (g) HCl (3.6 M in MeOH), rt, 82%; (h) Pd(dppf)Cl<sub>2</sub>, bis(pinacolato)diboron, KOAc, DMF, 80 °C, 90%; (i) 30% aq H<sub>2</sub>O<sub>2</sub>, EtOAc, rt, 85%; (j) ArBr, first-generation S-Phos precatalyst, LiHMDS, THF, 60 °C, 30–70%; (k) TsCl, pyridine, DMAP, rt, DCM, 55–80%; (l) <b>14</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 30–60%; (m) LiOH, H<sub>2</sub>O, THF, rt, 70–95%.</p></p></figure><div class="NLM_p">The synthesis of compounds where the C-ring (see <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) is substituted is depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. In order to introduce a 3-substituted piperidine ring (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), the synthesis began with commercially available racemic 3-fluoro-piperidin-4-one (<b>20a</b>) or 3-methyl-substituted piperidin-4-one (<b>20b</b>). L-Selectride-mediated reduction of ketones <b>20a</b>,<b>b</b> (with diastereoselectivity over 20:1) followed by TBS protection (using TBS-OTf) of the resulting <i>cis</i>-alcohol afforded intermediates <b>21a</b>,<b>b</b>. Hydrogenolysis of the benzyl group using 10% palladium on carbon under 1 atm H<sub>2</sub> provided amines of structure <b>22a</b>,<b>b</b>. Subsequent SN<sub>Ar</sub> reaction of the resulting amines <b>22a</b>,<b>b</b> with 4-bromo-5-chloro-2-methoxypyridine and K<sub>2</sub>CO<sub>3</sub> in DMSO at 100 °C gave a racemic adduct. At this point in the synthesis, the resulting racemic alcohols were subjected to chiral separation to give chiral alcohols <b>23a</b>,<b>b</b>. Next, displacement of the hydroxyl group in intermediates <b>23a</b>,<b>b</b> with phenol <b>14</b> was accomplished by Mitsunobu reaction using Bu<sub>3</sub>P and ADDP in toluene at elevated temperature (50 °C). The resulting methyl esters <b>24a</b>,<b>b</b> were hydrolyzed using LiOH in THF and H<sub>2</sub>O at room temperature to generate the corresponding fluoro (<b>25</b>) and methyl (<b>4</b>) analogues.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of C-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) L-Selectride, THF, −78 °C, 88–98%; (b) TBS-OTf, Et<sub>3</sub>N, DCM, 0 °C to rt, 76–92%; (c) H<sub>2</sub> (1 atm), Pd/C, MeOH, rt, 97–100%; (d) K<sub>2</sub>CO<sub>3</sub>, 100 °C, DMSO, TBAF, THF, rt; followed by chiral separation, 30–32%; (e) Bu<sub>3</sub>P, ADDP, toluene, rt, <b>14</b>, 54–64%; (f) LiOH, H<sub>2</sub>O, THF, rt, 78–80%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although the pharmacological origins of blood pressure and heart rate elevations observed with compound <b>2</b> (as well as hyperactivity associated with compound <b>1</b>) were unclear, we envisioned that increasing polarity and the sp<sup>3</sup>/sp<sup>2</sup> carbon ratio of our ligands may be beneficial in reducing off-target activities.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> Previous SARs demonstrated that the C-ring was promiscuous for GPR40 activity,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> so we decided to focus on replacing this portion of the molecule with a series of saturated heterocycles that were designed to maintain the distance and constrained nature of the phenyl C-ring (Structure A). As shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, pyrrolidine <b>26</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_001.pdf" class="ext-link">Supporting Information</a> for the synthesis of pyrrolidine analogues) demonstrated moderate but encouraging <i>h</i>GPR40 agonist activity. Following our previously described SAR for the series,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> incorporation of a 4-(<i>R</i>)-CF<sub>3</sub> substituent to the pyrrolidine ring led to significantly (7-fold) improved <i>in vitro</i> potency (e.g., <b>3b</b>) in this oxygenated piperidine C-ring series. Carbon-linked analogues (e.g., <b>27</b>) were less potent than the oxygen-linked analogues (e.g., <b>3b</b>) which was surprising given that carbon-linked analogues were more potent when the C-ring was phenyl (structures <b>1</b> and <b>2</b>). To determine if the pyrrolidine C-ring unit was optimal, pyrrolidine (<b>28</b>–<b>31</b>) analogues (generated following the same general chemical protocols as outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) were tested, but their GPR40 agonist activities were inferior to the oxygenated piperidine C-ring analogue.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. C-Ring SAR with a Pyrrolidine A Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0004.gif" alt="" id="GRAPHIC-d94e1004-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0005.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Standard deviation (SD) provided for results of <i>n</i> ≥ 3 tests; other EC<sub>50</sub>’s reported as the results of each separate test occasion.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">All compounds showed full activation as compared to compound <b>2</b> and DHA in this assay. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div></div><div></div></div><div class="NLM_p">When the C-ring piperidine was incorporated into the dihydropyrazole series (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), we discovered lead <b>3a</b> which exhibited not only potent <i>h</i>GPR40 activity but was devoid of PPARγ activity as well (<b>3a</b>, PPARγ EC<sub>50</sub> > 50 μM; <b>1</b>, PPARγ EC<sub>50</sub> = 4.4 μM; and <b>2</b>, PPARγ EC<sub>50</sub> = 2.6 μM). Unfortunately the electron donating nature of the piperidine nitrogen affected the metabolic fate of the D-ring, rendering it less stable to oxidative metabolism and glutathione (GSH) addition in liver microsomes. Compound <b>3a</b> also demonstrated increased (<i>vide infra</i>, <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) clearance in rodents due to demethylation of the methoxy group. We therefore set out to identify a compound with an improved PK profile and a reduced propensity for GSH adducts while maintaining the potency and selectivity profile of <b>3a</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> Activities of Substituted D-ring Analogs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0006.gif" alt="" id="GRAPHIC-d94e1082-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">D-ring</th><th class="colsep0 rowsep0" align="center">FLIPR <i>h</i>GPR40 EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">CLogP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="center">1.93</td><td class="colsep0 rowsep0" align="char" char=".">4.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="left">2-F-5-MeO-Ph</td><td class="colsep0 rowsep0" align="center">0.11 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">5.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left">2-Cl-Ph</td><td class="colsep0 rowsep0" align="center">0.45</td><td class="colsep0 rowsep0" align="char" char=".">6.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19c</b></td><td class="colsep0 rowsep0" align="left">2-Me-Ph</td><td class="colsep0 rowsep0" align="center">0.50</td><td class="colsep0 rowsep0" align="char" char=".">4.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19d</b></td><td class="colsep0 rowsep0" align="left">2-Et-Ph</td><td class="colsep0 rowsep0" align="center">1.18</td><td class="colsep0 rowsep0" align="char" char=".">5.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19e</b></td><td class="colsep0 rowsep0" align="left">3-MeO-Ph</td><td class="colsep0 rowsep0" align="center">0.62</td><td class="colsep0 rowsep0" align="char" char=".">4.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19f</b></td><td class="colsep0 rowsep0" align="left">4-Cl-Ph</td><td class="colsep0 rowsep0" align="center">6.27</td><td class="colsep0 rowsep0" align="char" char=".">5.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19g</b></td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="center">2.73, 2.55</td><td class="colsep0 rowsep0" align="char" char=".">4.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19h</b></td><td class="colsep0 rowsep0" align="left">3-F-4-MeO-Ph</td><td class="colsep0 rowsep0" align="center">3.62</td><td class="colsep0 rowsep0" align="char" char=".">4.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19i</b></td><td class="colsep0 rowsep0" align="left">2-F-6-MeO-Ph</td><td class="colsep0 rowsep0" align="center">5.90</td><td class="colsep0 rowsep0" align="char" char=".">5.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19j</b></td><td class="colsep0 rowsep0" align="left">2-F-6-Me-Ph</td><td class="colsep0 rowsep0" align="center">0.80</td><td class="colsep0 rowsep0" align="char" char=".">6.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19k</b></td><td class="colsep0 rowsep0" align="left">2,6-di-Me-Ph</td><td class="colsep0 rowsep0" align="center">1.34</td><td class="colsep0 rowsep0" align="char" char=".">5.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19l</b></td><td class="colsep0 rowsep0" align="left">2,6-di-Me-4-MeO-Ph</td><td class="colsep0 rowsep0" align="center">3.06</td><td class="colsep0 rowsep0" align="char" char=".">4.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19m</b></td><td class="colsep0 rowsep0" align="left">2-F-5-EtO-Ph</td><td class="colsep0 rowsep0" align="center">0.22</td><td class="colsep0 rowsep0" align="char" char=".">5.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19n</b></td><td class="colsep0 rowsep0" align="left">2-F-5-Me-Ph</td><td class="colsep0 rowsep0" align="center">0.44</td><td class="colsep0 rowsep0" align="char" char=".">6.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19o</b></td><td class="colsep0 rowsep0" align="left">2-F-5-Et-Ph</td><td class="colsep0 rowsep0" align="center">0.45, 0.72</td><td class="colsep0 rowsep0" align="char" char=".">6.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19p</b></td><td class="colsep0 rowsep0" align="left">2-F-5-iPr-Ph</td><td class="colsep0 rowsep0" align="center">0.60</td><td class="colsep0 rowsep0" align="char" char=".">6.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19q</b></td><td class="colsep0 rowsep0" align="left">2-F-5-Cl-Ph</td><td class="colsep0 rowsep0" align="center">0.51</td><td class="colsep0 rowsep0" align="char" char=".">6.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19r</b></td><td class="colsep0 rowsep0" align="left">2-Cl-5-F-Ph</td><td class="colsep0 rowsep0" align="center">0.36</td><td class="colsep0 rowsep0" align="char" char=".">6.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19s</b></td><td class="colsep0 rowsep0" align="left">2,5-di-Cl-Ph</td><td class="colsep0 rowsep0" align="center">0.25</td><td class="colsep0 rowsep0" align="char" char=".">6.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19t</b></td><td class="colsep0 rowsep0" align="left">2,5-di-F-Ph</td><td class="colsep0 rowsep0" align="center">0.48</td><td class="colsep0 rowsep0" align="char" char=".">5.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19u</b></td><td class="colsep0 rowsep0" align="left">2-Cl-5-MeO-Ph</td><td class="colsep0 rowsep0" align="center">0.10</td><td class="colsep0 rowsep0" align="char" char=".">5.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19v</b></td><td class="colsep0 rowsep0" align="left">2-Cl-5-Me-Ph</td><td class="colsep0 rowsep0" align="center">0.36</td><td class="colsep0 rowsep0" align="char" char=".">6.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19w</b></td><td class="colsep0 rowsep0" align="left">2-CN-5-MeO-Ph</td><td class="colsep0 rowsep0" align="center">0.68</td><td class="colsep0 rowsep0" align="char" char=".">5.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19x</b></td><td class="colsep0 rowsep0" align="left">2-pyridyl</td><td class="colsep0 rowsep0" align="center">2.61</td><td class="colsep0 rowsep0" align="char" char=".">3.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19y</b></td><td class="colsep0 rowsep0" align="left">6-F-2-pyridyl</td><td class="colsep0 rowsep0" align="center">0.39, 0.86</td><td class="colsep0 rowsep0" align="char" char=".">4.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19z</b></td><td class="colsep0 rowsep0" align="left">3-Me-6-F-2-pyridyl</td><td class="colsep0 rowsep0" align="center">0.37</td><td class="colsep0 rowsep0" align="char" char=".">4.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19aa</b></td><td class="colsep0 rowsep0" align="left">3-pyridyl</td><td class="colsep0 rowsep0" align="center">7.68</td><td class="colsep0 rowsep0" align="char" char=".">3.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19ab</b></td><td class="colsep0 rowsep0" align="left">2-F-5-MeO-4-pyridyl</td><td class="colsep0 rowsep0" align="center">0.15, 0.18</td><td class="colsep0 rowsep0" align="char" char=".">4.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19ac</b></td><td class="colsep0 rowsep0" align="left">2-Cl-5-MeO-4-pyridyl</td><td class="colsep0 rowsep0" align="center">0.11</td><td class="colsep0 rowsep0" align="char" char=".">4.27</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Standard deviation (SD) provided for results of <i>n</i> ≥ 3 tests; other EC<sub>50</sub>’s reported as the results of each separate test occasion.</p></div></div></div><div class="NLM_p">Since we identified the D-ring as the primary site of metabolism of <b>3a</b> (<i>vide infra</i>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), emphasis was placed on exploration of this portion of the molecule, focusing first on monosubstituted D-ring analogues (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Compared to unsubstituted analogue <b>19a</b>, ortho-substitution on the D-ring (<b>19b</b>–<b>d</b>) resulted in improved GPR40 activity, in contrast to para-substitution (<b>19f</b>, <b>19g</b>) which decreased activity. Both <i>o</i>-chloro (<b>19b</b>) and <i>m</i>-methoxy (<b>19e</b>) substituents exhibited a 4-fold improved activity, indicating the benefit of having a chloro-substituent at the <i>ortho</i>-position and a methoxy-substituent at the <i>meta</i>-position relative to the piperidine nitrogen attachment. A survey of di- and trisubstituted D-ring analogues revealed that 2,6- (<b>19i</b>–<b>j</b>), 3,4- (<b>19h</b>), and 2,4,6-substituted analogues (<b>19l</b>) were not in the desired potency range. Interestingly, 2,5-disubstitutions (<b>19m</b>–<b>w</b>) showed a positive effect on agonist activity and this substitution pattern was deemed to be optimal in this series.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Formation of oxidation metabolites and related GSH conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Unfortunately the D-ring substituents did not adequately address metabolism concerns. However, electron deficient heterocycles were introduced in an effort to reduce the potential for D-ring GSH adduct formation. As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, replacing the D-ring phenyl, as in compound <b>19a</b>, pyridine analogues (<b>19y</b>, <b>19z</b>, <b>19ab</b>, and <b>19ac</b>) showed a tendency toward improved potency. Surprisingly, the 2-chloro-5-methoxy-4-pyridine analogue (<b>19ac</b>) maintained similar <i>in vitro</i> potency as the lead compound <b>3a</b> despite different electronic characteristics of the D-ring.</div><div class="NLM_p">Since the piperidine C-ring seemed to provide preferred spatial placement of the B and D rings, we decided to evaluate conformational constraints in the piperidine group in an attempt to further increase potency. 3-Substituted piperidines were synthesized as shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. The introduction of fluorine (<b>32</b>, <b>25</b>) or/and methyl (<b>33</b>–<b>35</b>, <b>4</b>) group on the C-ring provided a significant improvement in EC<sub>50</sub> values. Methyl substitution (<b>4</b>) improves potency by ∼2-fold as compared to <b>3a</b>. [Analogues are counterscreened against a proprietary panel of GPCRs (including the related FFARs), NHRs, transporters, ion channels, and hERG. Compound <b>4</b> had no detectable activities below 10 μM against any counterscreen with the exception of MAO B (IC<sub>50</sub> = 6 μM).] With several analogues in the desired potency range in hand, biotransformation studies were initiated as a means to further differentiate between preferred compounds.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Re-exploration of C-Ring SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0008.gif" alt="" id="GRAPHIC-d94e1736-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0009.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Standard deviation (SD) provided for results of <i>n</i> ≥ 3 tests; other EC<sub>50</sub>’s reported as the results of each separate test occasion.</p></div></div><div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Biotransformation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><i>In vitro</i> biotransformation studies in liver microsomes on three advanced compounds (<b>3a</b>, <b>33</b> and <b>4</b>) highlighted significant differences with respect to metabolic stability and GSH adduct formation. The proposed pathways that lead to the formation of dealkylated and oxidized metabolites and glutathione conjugates are outlined in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. Compounds <b>3a</b>, <b>33</b> and <b>4</b> underwent CYP450-mediated oxidative dealkylation to form phenol-type metabolites (<b>36</b>, <b>37</b> and <b>38</b>, respectively) and oxidative GSH addition forms GSH adducts (<b>39</b> and <b>40</b>). As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, compound <b>3a</b> exhibited high amounts of demethylated and GSH-conjugated metabolites both in rat liver microsomes (RLM) and human liver microsomes (HLM) while compounds <b>33</b> and <b>4</b> showed a much lower percentage of the corresponding dealkylated/GSH adducts in both (human and mouse) microsomal preparations. We attribute the lack of GSH adducts to the introduction of an electron deficient pyridine (<b>4</b>) vs phenyl (<b>3a</b>) D-ring. Since high levels of GSH adducts are associated with an increased risk of idiosyncratic drug reactions,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> the metabolism profiles for <b>33</b> and <b>4</b> proved especially desirable. As a result of their improved metabolic profiles and potent GPR40 agonist activities, we selected these compounds for advanced <i>in vivo</i> evaluations.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Metabolic Fate of Compounds <b>3a</b>, <b>33</b>, and <b>4</b> in Liver Microsome Incubations<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">human liver microsomes</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">Rat liver microsomes</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">% parent compd remaining</th><th class="colsep0 rowsep0" align="center" char=".">% D-ring dealkylation metabolites</th><th class="colsep0 rowsep0" align="center" char=".">% GSH adducts</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">% parent compd remaining</th><th class="colsep0 rowsep0" align="center" char=".">% D-ring dealkylation metabolites</th><th class="colsep0 rowsep0" align="center" char=".">% GSH adducts</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="center" char=".">65</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">3–14</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="center" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char="."><1</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char="."><1</td><td class="colsep0 rowsep0" align="char" char=".">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="center" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">81</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The incubation mixtures contained test compound (1 or 3 μM), microsomal protein (1 mg/mL), NADPH (1 mM), phosphate buffer (100 mM, pH 7.4), and magnesium chloride (6.7 mM). The reaction, conducted in triplicate, was initiated by the addition of NADPH followed by incubation at 37 °C for 20 min. ND = not determined. See <a href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_001.pdf" class="ext-link">Supporting Information</a> for more detailed experimental procedure.</p></div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Pharmacokinetics</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The pharmacokinetic (PK) profiles of <b>3a</b>, <b>4</b>, and <b>33</b> across several species are shown in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>. As predicted by their improved microsomal stability profiles, compounds <b>4</b> and <b>33</b> showed improved PK profiles as compared to <b>3a</b>. Compounds <b>4</b> and <b>33</b> shared similar PK profiles with low clearance, moderate volume of distribution (<i>V</i><sub>ss</sub>), and moderate half-life in several preclinical species. However, in cynomologous monkeys, <b>33</b> showed higher clearance and <i>V</i><sub>ss</sub>, and shorter half-life than <b>4</b>, introducing some uncertainty over the projected human clearance of <b>33</b> relative to <b>4</b>. As such, compound <b>4</b> was selected for further advancement due to its superior cross-species PK profile.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Properties of Compounds <b>3a</b>, <b>4</b>, and <b>33</b> in Mouse, Rat, Dog, and Monkey</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">mouse</th><th class="rowsep1 colsep0" colspan="3" align="center">rat</th><th class="rowsep1 colsep0" colspan="3" align="center">monkey</th><th class="rowsep1 colsep0" colspan="2" align="center">dog</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK property</th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>33</b></th><th class="colsep0 rowsep0" align="center"><b>3a</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>33</b></th><th class="colsep0 rowsep0" align="center"><b>3a</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>33</b></th><th class="colsep0 rowsep0" align="center"><b>3a</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>33</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">dose iv/po (mg/kg)</td><td class="colsep0 rowsep0">1/1</td><td class="colsep0 rowsep0">1/–</td><td class="colsep0 rowsep0">1/3</td><td class="colsep0 rowsep0">1/3</td><td class="colsep0 rowsep0">1/3</td><td class="colsep0 rowsep0">1/3</td><td class="colsep0 rowsep0">0.5/1</td><td class="colsep0 rowsep0">0.5/–</td><td class="colsep0 rowsep0">0.2/0.5</td><td class="colsep0 rowsep0">0.5/1</td><td class="colsep0 rowsep0">0.5/–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0">6.0</td><td class="colsep0 rowsep0">ND<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0">3.4</td><td class="colsep0 rowsep0">3.5</td><td class="colsep0 rowsep0">3.2</td><td class="colsep0 rowsep0">1.1</td><td class="colsep0 rowsep0">1.4</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">0.2</td><td class="colsep0 rowsep0">1.2</td><td class="colsep0 rowsep0">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0">1</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">1</td><td class="colsep0 rowsep0">1.3</td><td class="colsep0 rowsep0">1.7</td><td class="colsep0 rowsep0">0.7</td><td class="colsep0 rowsep0">5</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">2</td><td class="colsep0 rowsep0">0.8</td><td class="colsep0 rowsep0">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0">3.1</td><td class="colsep0 rowsep0">3.3</td><td class="colsep0 rowsep0">1.5</td><td class="colsep0 rowsep0">4.0</td><td class="colsep0 rowsep0">3.4</td><td class="colsep0 rowsep0">1.4</td><td class="colsep0 rowsep0">13</td><td class="colsep0 rowsep0">9.4</td><td class="colsep0 rowsep0">5.3</td><td class="colsep0 rowsep0">5.2</td><td class="colsep0 rowsep0">7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">Cl (mL/min/kg)</td><td class="colsep0 rowsep0">2.0</td><td class="colsep0 rowsep0">1.6</td><td class="colsep0 rowsep0">6</td><td class="colsep0 rowsep0">3.4</td><td class="colsep0 rowsep0">5.0</td><td class="colsep0 rowsep0">17</td><td class="colsep0 rowsep0">0.7</td><td class="colsep0 rowsep0">4.0</td><td class="colsep0 rowsep0">6.6</td><td class="colsep0 rowsep0">2.2</td><td class="colsep0 rowsep0">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0">0.4</td><td class="colsep0 rowsep0">0.7</td><td class="colsep0 rowsep0">0.8</td><td class="colsep0 rowsep0">0.3</td><td class="colsep0 rowsep0">0.8</td><td class="colsep0 rowsep0">0.6</td><td class="colsep0 rowsep0">0.7</td><td class="colsep0 rowsep0">2.2</td><td class="colsep0 rowsep0">1.7</td><td class="colsep0 rowsep0">0.6</td><td class="colsep0 rowsep0">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">F%</td><td class="colsep0 rowsep0">100</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">96</td><td class="colsep0 rowsep0">47</td><td class="colsep0 rowsep0">89</td><td class="colsep0 rowsep0">36</td><td class="colsep0 rowsep0">61</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">66</td><td class="colsep0 rowsep0">62</td><td class="colsep0 rowsep0">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">ND = not determined.</p></div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Pharmacodynamics</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33026" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33026" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To assess the pharmacological effects of <b>4</b>, we performed an intraperitoneal glucose tolerance test (IPGTT) in 5 h fasted male mice, where compound (0.03–1 mg/kg) was administered orally 1 h prior to an intraperitoneal glucose challenge. As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, compound <b>4</b> dose-dependently suppressed plasma glucose excursion similar to that of our earlier advanced lead <b>1</b>. Administration of compound <b>4</b> as low as 0.1 mg/kg produced a glucose-lowering effect. Hypoglycemia was not observed at higher doses, consistent with the glucose-dependent nature of GPR40 action.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0015.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glucose-lowering effects of compound <b>4</b> in mice during an intraperitoneal glucose tolerance test (IPGTT).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To assess the ability of <b>4</b> to elicit GLP-1 secretion <i>in vivo</i>, an important part of the desired dual mechanism of action, we performed an oral glucose tolerance test (OGTT) in 5 h fasted mice in the presence and absence of the dipeptidylpeptidase-4 (DPP4) inhibitor BMS-538305.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> As GLP-1 is known to be rapidly cleaved in plasma, DPP4 inhibition is required to preserve the effect on compound induced active GLP-1 secretion. Any changes in active plasma GLP secretion upon co-administration may also suggest that pairing a GPR40 agonist with a DPP4 inhibitor could result in clinically relevant benefits on glucose homeostasis. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c, an oral dose of 3 mg/kg of compound <b>4</b> alone increased insulin levels and reduced plasma glucose excursion significantly but had a minimal effect on active GLP-1 levels (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b) due to rapid enzymatic proteolysis via DPP4. In combination with a DPP4 inhibitor, both active GLP-1 was increased and plasma glucose excursion was attenuated to an extent greater than either monotherapies, prior to and after the OGTT. Our results indicate that compound <b>4</b> not only enhances GSIS but also it promotes GLP-1 secretion <i>in vivo</i>. In summary, compound <b>4</b> showed significant glucose lowering effects via increased insulin and GLP-1 levels, demonstrating a desired dual mechanism of action <i>in vivo</i>.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Plasma glucose levels of compound <b>4</b> in mice during an oral glucose tolerance test (OGTT). (b) Plasma active GLP-1 levels of compound <b>4</b> in mice during an OGTT. (c) Plasma insulin levels of compound <b>4</b> in mice during an OGTT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">With the aim of developing highly selective and potent GPR40 agonists with favorable ADME properties, we employed strategies to increase polarity and the sp<sup>3</sup>/sp<sup>2</sup> carbon ratio, and to reduce undesired compound metabolism, leading to the identification of compound <b>4</b>. This compound showed potent and selective GPR40 full agonist activity with dual insulinotropic and GLP-1 secretory effects, resulting in robust plasma glucose lowering effects in acute animal models. Compound <b>4</b> also exhibited a favorable PK profile across preclinical species. The incorporation of a C-ring piperidine group paired with an optimized pyridyl D-ring functionality reduced GSH adduct formation, providing a path to compounds with reduced potential for idiosyncratic adverse reactions or off-target PPARγ activity. Based on its highly desirable drug developability profile, compound <b>4</b> was selected as a candidate for clinical development. Additional data on this compound will be reported in due course.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec8-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p">All anhydrous reactions were carried out using oven-dried glassware under an atmosphere of argon or nitrogen. All reagents and solvents were obtained from commercial vendors and used without further purification unless otherwise indicated. NMR spectra (<sup>1</sup>H, <sup>13</sup>C) were recorded on JEOL JNM-ECP500, JEOL GSX400, and Bruker 400 spectrometers. Chemical shifts are given in parts per million (ppm) downfield from internal reference tetramethylsilane standard; coupling constants (J values) were given in hertz (Hz). Elemental analyses were performed by the Bristol-Myers Squibb Discovery Analytical Science department. Melting points were taken on a Hoover Unimelt melting point apparatus and were uncorrected. LC/MS data were recorded on a Shimadzu LC-10AT equipped with a SIL-10A injector, a SPD-10AV detector normally operating at 220 nm, and interfaced to a Micromass ZMD mass spectrometer. LC/MS or HPLC retention times were reported using a Phenomenex Luna C-18 4.6 mm × 50 mm column eluting with a 4 min gradient of 0–100% solvent B, where solvent A was 10:90:0.1 CH<sub>3</sub>OH–H<sub>2</sub>O–TFA and solvent B was 90:10:0.1 CH<sub>3</sub>OH–H<sub>2</sub>O–TFA. Reactions were monitored by TLC using 0.25 mm E. Merck silica gel plates (60 F254) and were visualized using UV light and 5% phosphomolybdic acid in 95% EtOH. All compounds were found to be >95% pure by HPLC analysis unless otherwise noted.</div><div id="sec8-1-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure A: Compound <b>3a</b></h4><div id="sec8-1-1-1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> 1-(2-Fluoro-5-methoxyphenyl)piperidin-4-ol</h5><div class="NLM_p last">A round-bottomed flask containing a mixture of 2-bromo-1-fluoro-4-methoxybenzene (650 mg, 3.2 mmol) and piperidin-4-ol (800 mg, 7.9 mmol) in THF (3.2 mL) was purged with argon. First-generation S-Phos precatalyst ((2-dicyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl)[2-(2-aminoethylphenyl)]palladium(II) chloride) (48 mg, 0.063 mmol) was added to the vessel, followed by lithium bis(trimethylsilyl)amide (1 N in THF, 15 mL, 15 mmol). The flask was purged with argon at room temperature for several minutes, and then the reaction mixture was heated at 70 °C for 2.5 h. The resulting solution was diluted with aqueous NaHCO<sub>3</sub> and EtOAc, and the layers were extracted. The organic extract was washed successively with H<sub>2</sub>O and brine, and the organic layer was dried (MgSO<sub>4</sub>) and concentrated. Purification of the residue via silica gel chromatography gave the desired product as an oil (330 mg, 46% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 6.92 (1 H, dd, <i>J</i> = 12.09, 8.79 Hz), 6.51 (1 H, dd, <i>J</i> = 7.15, 3.30 Hz), 6.40 (1 H, dt, <i>J</i> = 8.79, 3.02 Hz), 3.85 (1 H, td, <i>J</i> = 8.52, 4.40 Hz), 3.76 (3 H, s), 3.27–3.46 (2 H, m), 2.74–2.91 (2 H, m), 1.95–2.14 (2 H, m), 1.75 (2 H, dtd, <i>J</i> = 12.85, 9.10, 9.10, 3.57 Hz), 1.45 (1 H, d, <i>J</i> = 4.40 Hz). <i>m/z</i> obs 226.2 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-1-2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> 1-(2-Fluoro-5-methoxyphenyl)piperidin-4-yl 4-methylbenzenesulfonate</h5><div class="NLM_p last">To a solution of 1-(2-fluoro-5-methoxyphenyl)piperidin-4-ol (1.0 g, 4.4 mmol) and 4-methylbenzene-1-sulfonyl chloride (1.7 g, 8.9 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) at room temperature was dropwise added pyridine (3.5 g, 44 mmol). The reaction mixture was stirred at room temperature for 16 h. The reaction mixture was diluted with EtOAc, and the organic layer was washed successively with H<sub>2</sub>O and brine. The resulting organic layer was dried (MgSO<sub>4</sub>) and concentrated. Purification of the residue via silica gel chromatography gave the desired product (light yellow solid, 1.5 g, 87% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.91–7.76 (m, <i>J</i> = 8.2 Hz, 2H), 7.40–7.30 (m, <i>J</i> = 8.2 Hz, 2H), 6.91 (dd, <i>J</i> = 12.1, 8.8 Hz, 1H), 6.52–6.33 (m, 2H), 4.79–4.58 (m, 1H), 3.75 (s, 3H), 3.22 (ddd, <i>J</i> = 11.8, 7.4, 3.8 Hz, 2H), 2.91 (ddd, <i>J</i> = 11.8, 7.4, 3.8 Hz, 2H), 2.46 (s, 3H), 2.05–1.84 (m, 4H). <i>m/z</i> obs 380.1 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-1-3" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Methyl 2-((4<i>S</i>,5<i>S</i>)-1-(4-((1-(2-fluoro-5-methoxyphenyl)piperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate</h5><div class="NLM_p last">To a solution of 1-(2-fluoro-5-methoxyphenyl)piperidin-4-yl 4-methylbenzenesulfonate (1.22 g, 3.0 mmol) and <b>14</b> (0.94 g, 3.0 mmol) in DMF (7 mL) was added cesium carbonate (2.2 g, 6.8 mmol). The reaction mixture was heated at 60 °C for 16 h. The reaction mixture was diluted with EtOAc, washed with H<sub>2</sub>O and brine, dried (MgSO<sub>4</sub>), and concentrated. Purification via silica gel chromatography gave the desired product as a gum (660 mg, 42% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.12–6.99 (m, 2H), 6.99–6.83 (m, 3H), 6.53 (dd, <i>J</i> = 7.1, 3.3 Hz, 1H), 6.41 (dt, <i>J</i> = 8.8, 3.3 Hz, 1H), 4.38 (tt, <i>J</i> = 7.1, 3.6 Hz, 2H), 3.81–3.73 (m, 3H), 3.72–3.67 (m, 3H), 3.33 (ddd, <i>J</i> = 11.4, 7.6, 3.6 Hz, 2H), 3.26–3.12 (m, 1H), 2.97 (ddd, <i>J</i> = 11.7, 8.1, 3.3 Hz, 2H), 2.80 (dd, <i>J</i> = 15.9, 3.3 Hz, 1H), 2.49–2.33 (m, 1H), 2.19–2.04 (m, 2H), 2.04–1.87 (m, 2H), 1.34 (d, <i>J</i> = 6.6 Hz, 3H). <i>m/z</i> obs 524.2 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-1-4" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> 2-((4<i>S</i>,5<i>S</i>)-1-(4-((1-(2-Fluoro-5-methoxyphenyl)piperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetic acid (<b>3a</b>)</h5><div class="NLM_p last">To a solution of methyl 2-((4<i>S</i>,5<i>S</i>)-1-(4-((1-(2-fluoro-5-methoxyphenyl)piperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate (530 mg, 1.0 mmol) in THF (20 mL) was added lithium hydroxide (1 N in water, 1.4 mL, 1.4 mmol), and the mixture was stirred at room temperature. After 16 h, lithium hydroxide (1 N, 2.6 mL, 2.6 mmol) was added, and the reaction mixture was stirred at room temperature for 3 h. The reaction mixture was cooled with an ice–water bath, and the solution was acidified with 1 N HCl. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic extracts were dried (MgSO<sub>4</sub>), filtered, and concentrated, and the residue was purified via reverse-phase Prep HPLC. The product-containing fractions were evaporated, the residue was treated with CH<sub>3</sub>CN and 1 N HCl, and the mixture was lyophilized to give <b>3a</b> as a light yellow solid (480 mg, 84% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>CN) δ ppm 7.13–7.07 (m, 2H), 7.07–7.03 (m, 1H), 7.01–6.96 (m, 2H), 6.74 (dd, <i>J</i> = 7.2, 3.0 Hz, 1H), 6.61 (dt, <i>J</i> = 8.9, 3.3 Hz, 1H), 5.67 (br s, 1H), 4.53–4.47 (m, 1H), 4.47–4.42 (m, 1H), 3.79 (s, 3H), 3.46 (ddd, <i>J</i> = 11.6, 7.6, 3.6 Hz, 2H), 3.40–3.32 (m, 1H), 3.11 (ddd, <i>J</i> = 11.9, 8.2, 3.3 Hz, 2H), 2.75 (dd, <i>J</i> = 16.5, 3.0 Hz, 1H), 2.52 (dd, <i>J</i> = 16.5, 9.6 Hz, 1H), 2.21–2.13 (m, 2H), 2.00 (s, 1H), 1.96–1.89 (m, 2H), 1.33 (d, <i>J</i> = 7.2 Hz, 3H). <i>m/z</i> obs 510.2 [M + H]<sup>+</sup>.</div></div></div><div id="sec8-1-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Procedure B: Compound <b>4</b></h4><div id="sec8-1-2-1" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 2-((4<i>S</i>,5<i>S</i>)-1-(4-(((3<i>R</i>,4<i>R</i>)-1-(5-Chloro-2-methoxypyridin-4-yl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetic acid (<b>4</b>)</h5><div class="NLM_p last">To a stirred solution of methyl 2-((4<i>S</i>,5<i>S</i>)-1-(4-(((3<i>R</i>,4<i>R</i>)-1-(5-chloro-2-methoxypyridin-4-yl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate (5.5 g, 9.9 mmol) in THF (90 mL) and water (9 mL) at room temperature was added 2 N LiOH solution (12 mL, 24 mmol). The reaction mixture was stirred at room temperature for 16 h, and 1 N HCl (25 mL, 25 mmol) was added at 0 °C to pH = 4–5. The solvent was evaporated, and the residue was extracted three times with EtOAc. The organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>; the solution was filtered and concentrated. The residue was recrystallized from isopropanol to give <b>4</b> (neutral form) as white solid (4.3 g, 7.7 mmol, 78% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.52 (br s, 1H), 8.01 (s, 1H), 7.05 (d, <i>J</i> = 9.1 Hz, 2H), 6.96 (d, <i>J</i> = 9.1 Hz, 2H), 6.40 (s, 1H), 4.49–4.33 (m, 1H), 4.02 (td, <i>J</i> = 8.8, 4.1 Hz, 1H), 3.80 (s, 3H), 3.56–3.39 (m, 2H), 3.37–3.29 (m, 1H), 2.94–2.85 (m, 1H), 2.72–2.66 (m, 1H), 2.64 (dd, <i>J</i> = 16.1, 2.9 Hz, 1H), 2.49–2.41 (m, 1H), 2.22–2.05 (m, 1H), 2.01–1.86 (m, 1H), 1.68–1.50 (m, 1H), 1.25 (d, <i>J</i> = 7.2 Hz, 3H), 1.03 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.5, 163.7, 157.1, 152.5, 146.3, 139.7 (q, <i>J</i> = 34.7 Hz), 136.2, 121.7 (q, <i>J</i> = 269.3 Hz), 117.3, 117.2, 116.0, 100.4, 78.9, 65.6, 54.2, 53.4, 47.8, 44.2, 36.0, 34.9, 29.5, 17.4, 15.3. <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>) δ −61.94 (s, 3F). Optical rotation: [α]<sub>D</sub><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> −11.44 (<i>c</i> 2.01, MeOH). HRMS (ESI/HESI) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>25</sub>H<sub>29</sub>ClF<sub>3</sub>N<sub>4</sub>O<sub>4</sub> 541.1824; Found 541.1813. HPLC (Orthogonal method, 30% Solvent B start): RT = 11.9 min, HI: 97%. <i>m/z</i> obs 541.0 [M + H]<sup>+</sup>. Melting point = 185.5 °C.</div></div><div id="sec8-1-2-2" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> <i>N</i>′-(4-Bromophenyl)-2,2,2-trifluoroacetohydrazide (<b>6</b>)</h5><div class="NLM_p last">To a stirred suspension of (4-bromophenyl)hydrazine hydrochloride (100 g, 447 mmol) in DCM (1.5 L) at room temperature was added dropwise a solution of TFAA (68.4 mL, 492 mmol) in DCM (150 mL). The reaction mixture was stirred at room temperature for 2 h, and additional TFAA (45 mL, 324 mmol) was added slowly to the reaction mixture. After 5 min, the homogeneous reaction was judged complete by LCMS. The reaction mixture was concentrated and diluted with hexane (∼1 L), resulting in an off-white crystalline precipitate. The mixture was filtered, and the solids were rinsed with hexanes. The resulting solid was dried under high vacuum for 12 h at 50 °C to give <b>6</b> (103 g, 364 mmol, 81% yield) as an off-white crystalline compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (br s, 1H), 7.46–7.33 (m, 2H), 6.79–6.67 (m, 2H), 6.06 (br s, 1H). <i>m/z</i> obs 305 [M + Na]<sup>+</sup>.</div></div><div id="sec8-1-2-3" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> (<i>S,E</i>)-3-But-2-enoyl-4-phenyloxazolidin-2-one (<b>7</b>)</h5><div class="NLM_p last">To a solution of (<i>S</i>)-(+)-4-phenyl-2-oxazolidinone (84 g, 517 mmol), lithium chloride (23 g, 540 mmol), and triethylamine (79 mL, 560 mmol) in THF (1.2 L) in a 5 L three-neck flask at −5 °C was added crotonic anhydride (76 mL, 512 mmol) over 5 min. The reaction temperature increased slightly during the addition. The mixture was allowed to warm to room temperature, resulting in a white milky solution. The reaction mixture was stirred at room temperature overnight. Upon completion, as monitored by LCMS, the reaction was quenched with 0.2 M aqueous HCl (600 mL) to give an aqueous layer of pH ∼7. The two layers were separated, and the aqueous layer was extracted with EtOAc (400 mL). The combined EtOAc and THF layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give a light brown oil (200 mL). To the oil was added MeOH (200 mL). Crystals formed slowly at the beginning and continued to precipitate over 15 min. The product was collected by filtration and rinsed with MeOH (200 mL) to give a white solid. Additional product was collected from the MeOH filtrate, and the materials were combined and dried to give 102 g of <b>7</b> (85%, 439 mmol) as white crystals. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.57–7.22 (m, 6H), 7.21–6.84 (m, 1H), 5.52 (dd, <i>J</i> = 8.8, 4.0 Hz, 1H), 4.73 (t, <i>J</i> = 8.8 Hz, 1H), 4.42–4.19 (m, 1H), 2.11–1.88 (m, 3H). <i>m/z</i> obs 231.9 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-4" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> (<i>S</i>)-3-((4<i>S</i>,5<i>R</i>)-1-(4-Bromophenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazole-5-carbonyl)-4-phenyloxazolidin-2-one (<b>8</b>)</h5><div class="NLM_p last">To a solution of <b>6</b> (110 g, 390 mmol) in EtOAc (1500 mL) at room temperature was added dropwise benzenesulfonyl chloride (54 mL, 410 mmol). The mixture was cooled to 0 °C, and Hunig’s base (73 mL, 410 mmol) was added dropwise. The resulting mixture was stirred at room temperature overnight, and the reaction was judged complete as monitored by LCMS. The mixture was diluted with EtOAc, and the organic layer was washed with water (3 × 2L). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated to give (<i>Z</i>)-<i>N</i>′-(4-bromophenyl)-2,2,2-trifluoroacetohydrazonoyl chloride (120 g, 390 mmol) as a yellow liquid, which was used for next step without further purification. To a solution of (<i>Z</i>)-<i>N</i>′-(4-bromophenyl)-2,2,2-trifluoroacetohydrazonoyl chloride (94 g, 310 mmol) and <b>7</b> (65 g, 280 mmol) in 1,4-dioxane (780 mL) under N<sub>2</sub> at 1 atm was added silver(I) carbonate (100 g, 380 mmol), and the mixture was stirred at 50 °C overnight. The reaction was monitored via LCMS until the starting material was no longer detected. The reaction mixture was filtered through Celite, and the filter cake was washed with EtOAc. The filtrate was concentrated to give an oil. The residue was purified via crystallization from hexanes–ether (7:3) to give <b>8</b> (72 g, 140 mmol, 46% yield) as a white crystalline solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.47–7.31 (m, 5H), 7.29–7.20 (m, 3H), 6.93–6.81 (m, 2H), 5.81 (d, <i>J</i> = 2.2 Hz, 1H), 5.39 (dd, <i>J</i> = 8.8, 4.2 Hz, 1H), 4.82 (t, <i>J</i> = 9.0 Hz, 1H), 4.43 (dd, <i>J</i> = 9.2, 4.2 Hz, 1H), 3.16 (dd, <i>J</i> = 7.0, 1.5 Hz, 1H), 1.50 (d, <i>J</i> = 7.0 Hz, 3H). <i>m/z</i> obs 496.0 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-5" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> ((4<i>S</i>,5<i>R</i>)-1-(4-Bromophenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)methanol (<b>9</b>)</h5><div class="NLM_p last">To a solution of <b>8</b> (94g, 190 mmol) in THF (1.4 L) was added a solution of NaBH<sub>4</sub> (7.0 g, 190 mmol) in water (57 mL) in two portions. The resulting mixture was stirred at room temperature for 4 h until the reaction was judged complete as monitored by LCMS. The reaction mixture was cooled to 2 °C, and 10% KHSO<sub>4</sub> (180 mL) was added while the internal temperature was maintained at <10 °C. The resulting mixture was stirred for 30 min and evaporated. The residue was diluted with EtOAc (900 mL) and water (900 mL). The layers were extracted, and the organic layer was washed with brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, and the solution was filtered and evaporated to give 100 g of a white semisolid that was purified via silica gel chromatography to give 60 g of <b>9</b> (94%, 180 mmol) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.46–7.35 (m, 2H), 7.10–6.95 (m, 2H), 4.07 (q, <i>J</i> = 4.6 Hz, 1H), 3.90–3.69 (m, 2H), 3.55–3.39 (m, 1H), 1.63–1.49 (m, 1H), 1.36 (dd, <i>J</i> = 7.2, 0.6 Hz, 3H). <i>m/z</i> obs 337 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-6" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> ((4<i>S</i>,5<i>R</i>)-1-(4-Bromophenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)methylmethanesulfonate (<b>10</b>)</h5><div class="NLM_p last">To a cooled (0–5 °C) solution of <b>9</b> (85 g, 250 mmol) in THF (750 mL) were added triethylamine (70 mL, 500 mmol) and methanesulfonyl chloride (23 mL, 290 mmol). A white precipitate was observed. The mixture was stirred at room temperature for 30 min, and the reaction was judged complete as monitored by LCMS. The mixture was diluted with EtOAc (250 mL) and saturated aqueous NaHCO<sub>3</sub>. The layers were extracted, and the aqueous layer was back extracted with EtOAc. The combined organic layers were washed successively with water and brine. The organic layer was dried over MgSO<sub>4</sub>, and the solution was filtered and evaporated to give <b>10</b> (100 g, 250 mmol, 98% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.48–7.39 (m, 2H), 7.07–6.99 (m, 2H), 4.42–4.30 (m, 2H), 4.19–4.08 (m, 1H), 3.50–3.37 (m, 1H), 2.98 (d, <i>J</i> = 1.0 Hz, 3H), 1.38 (d, <i>J</i> = 7.3 Hz, 3H). <i>m/z</i> obs 417.0 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-7" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 2-((4<i>S</i>,5<i>S</i>)-1-(4-Bromophenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetonitrile (<b>11</b>)</h5><div class="NLM_p last">A suspension of KCN (9.9 g, 150 mmol) in DMSO (700 mL) was heated to 60 °C for 1 h and cooled to 40 °C. To this mixture was added a solution of <b>10</b> (51 g, 120 mmol) in 50 mL of DMSO. The mixture was heated at 40 °C for 9 h. The reaction mixture was cooled in an ice bath and stirred overnight. The reaction mixture was diluted with ice (450 g), EtOAc (500 mL), and saturated aqueous NaHCO<sub>3</sub> solution (250 mL). The mixture was stirred for 15 min, and the layers were separated. The aqueous layer was extracted with EtOAc (200 mL), and the combined organic layers were washed with brine. The organic layer was dried over MgSO<sub>4</sub>, filtered, and evaporated to give <b>11</b> (39 g, 110 mmol, 92% yield) as a slight reddish oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.53–7.39 (m, 2H), 7.07–6.92 (m, 2H), 4.36–4.24 (m, 1H), 3.56–3.31 (m, 1H), 2.78 (dd, <i>J</i> = 16.9, 3.5 Hz, 1H), 2.50 (dd, <i>J</i> = 16.9, 9.0 Hz, 1H), 1.48–1.36 (m, 3H). <i>m/z</i> obs 348.0 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-8" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Methyl 2-((4<i>S</i>,5<i>S</i>)-1-(4-Bromophenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate (<b>12</b>)</h5><div class="NLM_p last">To a cooled (0 °C) solution of methanol (1 L) and dichloromethane (1.5 L) was added acetyl chloride (0.33 L, 4.7 mol) over 45 min. The resulting mixture was stirred for 1 h, <b>11</b> (90 g, 0.26 mol) was added, and the mixture was stirred for 2 h at room temperature. The reaction mixture was evaporated <i>in vacuo</i>, and the residue was treated with a solution of HCl/methanol/dichloromethane as generated above. After being stirred overnight at room temperature, the reaction mixture was evaporated <i>in vacuo</i>, and the residue was redissolved in HCl/methanol that had been formed separately by mixing methanol with acetyl chloride as above—1 L of methanol treated with 0.33 L of acetyl chloride at 0 °C for 45 min. The reaction mixture was stirred at room temperature overnight, and then it was heated at 40 °C for 1 h. The solution was diluted with 1 L of acetonitrile, and the mixture was evaporated <i>in vacuo</i>. The residue was dissolved in ethyl acetate, and the mixture was washed successively with saturated aqueous NaHCO<sub>3</sub> and brine. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, the mixture was filtered, and the solution was evaporated. The residue was purified via silica chromatography to give 81 g of <b>12</b> (82%, 210 mmol) as a light yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.43–7.37 (m, 2 H), 7.01–6.94 (m, 2 H), 4.45–4.37 (m, 1 H), 3.72 (s, 3 H), 3.23–3.15 (m, 1 H), 2.79 (dd, J = 3.0, 16.3 Hz, 1 H), 2.41 (dd, J = 10.3, 16.3 Hz, 1 H), 1.34 (d, J = 7.0 Hz, 3 H). <sup>13</sup>C NMR (300 MHz,CDCl<sub>3</sub>) δ 170.57, 142.50, 132.29, 129.58, 123.02, 119.45, 115.78, 113.60, 77.43, 65.06, 52.08, 45.52, 34.81, 17.70. <sup>19</sup>F NMR (400 MHz, CDCl<sub>3</sub>) δ −63.25. <i>m/z</i> obs 379.5 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-9" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Methyl 2-((4<i>S</i>,5<i>S</i>)-4-Methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate (<b>13</b>)</h5><div class="NLM_p last">A vessel containing a mixture of <b>12</b> (1.5 g, 4.0 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (1.6 g, 6.4 mmol), potassium acetate (1.3 g, 13 mmol), and 1,1′-(diphenylphosphino)ferrocene)palladium dichloride (0.16 g, 0.20 mmol) in DMF (8 mL) was purged with argon. The reaction mixture was heated at 80 °C for 72 h. The resulting solution was diluted with EtOAc, washed with H<sub>2</sub>O and brine, dried (MgSO<sub>4</sub>), and concentrated. Purification via silica gel chromatography gave the desired product as a gum (1.5 g, 3.6 mmol, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.68 (d, <i>J</i> = 8.5 Hz, 2H), 7.00 (d, <i>J</i> = 8.5 Hz, 2H), 4.41 (d, <i>J</i> = 10.5 Hz, 1H), 3.65 (s, 3H), 3.20–3.02 (m, 1H), 2.77 (dd, <i>J</i> = 16.3, 2.8 Hz, 1H), 2.34 (dd, <i>J</i> = 16.3, 10.3 Hz, 1H), 1.28–1.24 (m, 15H). <i>m/z</i> obs 427.3 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-10" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Methyl 2-((4<i>S</i>,5<i>S</i>)-1-(4-Hydroxyphenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate (<b>14</b>)</h5><div class="NLM_p last">To a solution of <b>13</b> (1.5 g, 3.5 mmol) in ethyl acetate (35 mL) was dropwise added hydrogen peroxide (30 wt% in water, 3.6 mL, 35 mmol). The reaction mixture was stirred at room temperature. After being stirred at room temperature for 7 h, the reaction mixture was cooled with an ice–water bath, and the reaction was slowly quenched with saturated aqueous sodium sulfite. The mixture was extracted with EtOAc. The organic extracts were washed with brine, dried (MgSO<sub>4</sub>), and concentrated. Purification via silica gel chromatography gave <b>14</b> as an oil (0.95 g, 85% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.03 (d, <i>J</i> = 8.3 Hz, 2H), 6.83 (d, <i>J</i> = 8.0 Hz, 2H), 4.55 (s, 1H), 4.40 (d, <i>J</i> = 8.5 Hz, 1H), 3.72 (s, 3H), 3.28–3.12 (m, 1H), 2.79 (dd, <i>J</i> = 16.1, 2.5 Hz, 1H), 2.42 (dd, <i>J</i> = 15.9, 10.2 Hz, 1H), 1.42–1.32 (m, 3H). <sup>19</sup>F NMR (400 MHz, CDCl<sub>3</sub>) δ −63.47. <i>m/z</i> obs 317.2 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-11" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> <i>rac</i>-1-Benzyl-3-<i>cis</i>-methylpiperidin-4-ol</h5><div class="NLM_p last">To a solution of 1-benzyl-3-methylpiperidin-4-one (25 g, 120 mmol) in THF (100 mL) at −78 °C was added dropwise a 1 M solution of L-Selectride (180 mL, 180 mmol) in THF. The reaction mixture was stirred at −78 °C for 1 h 30 min. To this solution were added EtOH (22 mL), water (55 mL), and 1 M NaOH (55 mL). The reaction mixture was warmed to 0 °C, and 30% aqueous H<sub>2</sub>O<sub>2</sub> (55 mL) was added dropwise. The reaction mixture was warmed to room temperature with stirring for 2 h. The reaction mixture was diluted with EtOAc, and the insoluble white solid was filtered. The filtrate was washed with saturated NaHCO<sub>3</sub>, H<sub>2</sub>O/brine, and brine, dried (MgSO<sub>4</sub>), filtered, and concentrated to give the crude product as an oil. Purification via silica gel chromatography gave <i>rac</i>-1-benzyl-3-<i>cis</i>-methylpiperidin-4-ol as a white solid (22 g, 88% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.40–7.20 (m, 5H), 3.84 (s, 1H), 3.55 (s, 2H), 2.60–1.73 (m, 7H), 0.97 (d, 3H).</div></div><div id="sec8-1-2-12" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>rac</i>-1-Benzyl-4-<i>cis</i>-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methylpiperidine (<b>21b</b>)</h5><div class="NLM_p last">To a solution of <i>rac</i>-1-benzyl-3-<i>cis</i>-methylpiperidin-4-ol (22 g, 110 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (110 mL) and triethylamine (45 mL, 320 mmol) at 0 °C was added <i>tert</i>-butyldimethylsilyl trifluoromethanesulfonate (29 mL, 130 mmol). The reaction mixture was stirred at 0 °C for 1 h. Saturated aqueous NaHCO<sub>3</sub> (180 mL) was added slowly to the reaction mixture. The solution was concentrated, diluted with EtOAc, and washed successively with H<sub>2</sub>O and brine, and the resulting organic layer was dried (MgSO<sub>4</sub>) and concentrated. Purification via silica gel chromatography gave <b>21b</b> as an oil (32 g, 92% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33–7.19 (m, 5H), 3.73 (d, <i>J</i> = 3.3 Hz, 1H), 3.45 (br s, 2H), 2.44 (br s, 1H), 2.34 (br s, 2H), 2.12 (t, <i>J</i> = 9.9 Hz, 1H), 1.84–1.50 (m, 3H), 0.92–0.84 (m, 9H), 0.82 (d, <i>J</i> = 7.0 Hz, 3H), 0.00 (s, 6H). <i>m/z</i> obs 320.3 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-13" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> <i>rac</i>-<i>cis-</i>4-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methylpiperidine (<b>22b</b>)</h5><div class="NLM_p last">A mixture of <b>21b</b> (16 g, 49 mmol) and 10% palladium on carbon (3.2 g) in MeOH (500 mL) was stirred at room temperature under hydrogen atmosphere (1 atm, balloon) for 24 h. The mixture was filtered through Celite, and the filtrate was concentrated to give <b>22b</b> as an oil (11 g, 100% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.80 (s, 1H), 2.90 (m, 1H), 2.70–2.50 (m, 4H), 1.60–1.50 (m, 3H), 0.86 (s, 9H), 0.80 (d, 3H), 0.00 (s, 6H).</div></div><div id="sec8-1-2-14" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>rac</i>-4-(<i>cis-</i>4-((<i>tert</i>-Butyldimethylsilyl)oxy)-3-methylpiperidin-1-yl)-5-chloro-2-methoxypyridine</h5><div class="NLM_p last">A mixture of 4-bromo-5-chloro-2-methoxypyridine (9.7 g, 44 mmol), <b>22b</b> (10 g, 44 mmol), and K<sub>2</sub>CO<sub>3</sub> (12 g, 87 mmol) in DMSO (15 mL) was vigorously stirred at 100 °C overnight. The reaction mixture was diluted with water, and the mixture was extracted with EtOAc. The organic extract was washed successively with H<sub>2</sub>O and brine, and the resulting organic layer was dried (MgSO<sub>4</sub>) and concentrated. Purification via silica gel chromatography gave <i>rac</i>-4-(<i>cis-</i>4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methylpiperidin-1-yl)-5-chloro-2-methoxypyridine as an oil (14 g, 77% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.88 (s, 1H), 6.21 (s, 1H), 3.83–3.79 (m, 4H), 3.19 (dtd, <i>J</i> = 11.7, 3.9, 1.8 Hz, 1H), 3.07–2.99 (m, 2H), 2.78 (t, <i>J</i> = 11.0 Hz, 1H), 1.93–1.81 (m, 1H), 1.81–1.74 (m, 1H), 1.73–1.63 (m, 1H), 0.89–0.82 (m, 12H), 0.00 (s, 6H). <i>m/z</i> obs 371.2 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-15" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> <i>rac</i>-1-(5-Chloro-2-methoxypyridin-4-yl)-3-<i>cis-</i>methylpiperidin-4-ol</h5><div class="NLM_p last">To a mixture of <i>rac</i>-4-(<i>cis</i>-4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-methylpiperidin-1-yl)-5-chloro-2-methoxypyridine (10 g, 27 mmol)) in THF (27 mL) was added TBAF (81 mL, 81 mmol). The reaction was stirred at 23 °C for 16 h. To the reaction mixture was slowly added saturated aqueous NaHCO<sub>3</sub> (100 mL), and the resulting mixture was extracted with EtOAc (2 × 100 mL). The combined organic extracts were washed successively with water (50 mL) and brine (50 mL), and the organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. Purification via silica gel chromatography gave <i>rac</i>-1-(5-chloro-2-methoxypyridin-4-yl)-3-<i>cis</i>-methylpiperidin-4-ol as a white foam (7g, 99% yield). <sup>1</sup>H NMR (400 MHz,CDCl<sub>3</sub>) δ 7.98 (s, 1H), 6.30 (s, 1H), 3.99–3.94 (m, 1H), 3.91 (s, 3H), 3.30–3.21 (m, 1H), 3.18–3.09 (m, 2H), 2.93 (dd, <i>J</i> = 11.5, 10.0 Hz, 1H), 2.08 (qd, <i>J</i> = 6.8, 3.1 Hz, 1H), 2.02–1.87 (m, 2H), 1.42 (d, <i>J</i> = 3.8 Hz, 1H), 1.06 (d, <i>J</i> = 7.0 Hz, 3H). <i>m/z</i> obs 257.0 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-16" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> (3<i>R</i>,4<i>S</i>)-1-(5-Chloro-2-methoxypyridin-4-yl)-3-methylpiperidin-4-ol (<b>23b</b>)</h5><div class="NLM_p last"><i>rac</i>-1-(5-Chloro-2-methoxypyridin-4-yl)-3-<i>cis</i>-methylpiperidin-4-ol (9.6 g, 37 mmol) isomers were separated by chiral preparative SFC to provide <b>23b</b> (white foam, 4 g, 16 mmol) as a single enantiomer. <sup>1</sup>H NMR (400 MHz,CDCl<sub>3</sub>) δ 7.98 (s, 1H), 6.30 (s, 1H), 3.99–3.94 (m, 1H), 3.91 (s, 3H), 3.30–3.21 (m, 1H), 3.18–3.09 (m, 2H), 2.93 (dd, <i>J</i> = 11.5, 10.0 Hz, 1H), 2.08 (qd, <i>J</i> = 6.8, 3.1 Hz, 1H), 2.02–1.87 (m, 2H), 1.42 (d, <i>J</i> = 3.8 Hz, 1H), 1.06 (d, <i>J</i> = 7.0 Hz, 3H). <i>m/z</i> obs 257.0 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-2-17" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 2-((4<i>S</i>,5<i>S</i>)-1-(4-(((3<i>R</i>,4<i>R</i>)-1-(5-Chloro-2-methoxypyridin-4-yl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate</h5><div class="NLM_p last">To a solution of <b>14</b> (4.6 g, 15 mmol) and <b>23b</b> (3.4 g, 13 mmol) in toluene (170 mL) was added tributylphosphine (5.5 mL, 21 mmol). While stirring, (<i>E</i>)-diazene-1,2-diylbis(piperidin-1-ylmethanone) (5.4 g, 21 mmol) was added portionwise to the reaction mixture, and the resulting mixture was heated at 50 °C for 120 min. The mixture was cooled to room temperature, 150 mL of hexanes was added to the mixture, and a white precipitate formed. The mixture was filtered, and the filtrate was concentrated and purified via silica gel chromatography to give methyl 2-((4<i>S</i>,5<i>S</i>)-1-(4-(((3<i>R</i>,4<i>R</i>)-1-(5-chloro-2-methoxypyridin-4-yl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate (4.7 g, 8.5 mmol, 64% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.00 (s, 1H), 7.15–7.04 (m, 2H), 7.01–6.89 (m, 2H), 6.30 (s, 1H), 4.49–4.36 (m, 1H), 3.91 (s, 4H), 3.73 (s, 3H), 3.62–3.49 (m, 2H), 3.28–3.15 (m, 1H), 2.95–2.85 (m, 1H), 2.82 (dd, <i>J</i> = 16.2, 3.2 Hz, 1H), 2.67 (dd, <i>J</i> = 12.3, 9.0 Hz, 1H), 2.43 (dd, <i>J</i> = 16.1, 10.3 Hz, 1H), 2.26–2.12 (m, 2H), 1.91–1.78 (m, 1H), 1.36 (d, <i>J</i> = 7.0 Hz, 3H), 1.16 (d, <i>J</i> = 6.6 Hz, 3H). <i>m/z</i> obs 555.2 [M + H]<sup>+</sup>.</div></div></div><div id="sec8-1-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> General Procedure C: Compound <b>33</b></h4><div id="sec8-1-3-1" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 5-Ethoxy-2-fluoroaniline</h5><div class="NLM_p last">To a solution of (5-ethoxy-2-fluorophenyl)boronic acid (10 g, 55.0 mmol) in MeOH (220 mL) was added 14.8 M aqueous NH<sub>4</sub>OH (19 mL, 280 mmol) followed by the addition of cuprous oxide (1.6 g, 11.0 mmol). The reaction mixture was stirred under air for 7 h, and the reaction mixture was concentrated. The crude material was dissolved in EtOAc/Hex (2:1). The mixture was filtered through Celite, and the solution was concentrated. The crude material was purified by flash chromatography to provide 5-ethoxy-2-fluoroaniline (4.1 g, 26 mmol, 48% yield) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.86 (dd, <i>J</i> = 10.9, 8.8 Hz, 1H), 6.32 (dd, <i>J</i> = 7.5, 2.9 Hz, 1H), 6.20 (dt, <i>J</i> = 8.8, 3.3 Hz, 1H), 3.94 (q, <i>J</i> = 6.9 Hz, 2H), 3.68 (br s, 2H), 1.37 (t, <i>J</i> = 6.9 Hz, 3H). <i>m/z</i> obs 156.1 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-3-2" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 1-Benzyl-1,3-dimethyl-4-oxopiperidin-1-ium, Iodide Salt</h5><div class="NLM_p last">To a solution of 1-benzyl-3-methylpiperidin-4-one (14 g, 69 mmol) in acetone (69 mL) at room temperature was dropwise added MeI (8.6 mL, 140 mmol). The reaction mixture was concentrated to obtain 1-benzyl-1,3-dimethyl-4-oxopiperidin-1-ium, iodide salt (24 g, 69 mmol, 100% yield) as a light yellow foam. <i>m/z</i> obs 219.2 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-3-3" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 1-(5-Ethoxy-2-fluorophenyl)-3-methylpiperidin-4-one</h5><div class="NLM_p last">To a solution of 5-ethoxy-2-fluoroaniline (7.9 g, 51 mmol) in EtOH (100 mL) were added K<sub>2</sub>CO<sub>3</sub> (1.0 g, 7.6 mmol), 1-benzyl-1,3-dimethyl-4-oxopiperidin-1-ium, iodide salt (26 g, 76 mmol), and water (47 mL). The reaction mixture was heated to 95 °C overnight. The reaction mixture was cooled to room temperature and diluted with EtOAc/water. The layers were separated, and the aqueous layer was extracted with EtOAc (2×). The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), and concentrated. The crude product was purified by flash chromatography to provide 1-(5-ethoxy-2-fluorophenyl)-3-methylpiperidin-4-one (10 g, 40 mmol, 79% yield) as a colorless oil, which solidified overnight. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.95 (dd, <i>J</i> = 12.1, 8.8 Hz, 1H), 6.52 (dd, <i>J</i> = 7.5, 2.9 Hz, 1H), 6.44 (dt, <i>J</i> = 8.8, 3.2 Hz, 1H), 3.98 (q, <i>J</i> = 7.3 Hz, 2H), 3.75–3.64 (m, 2H), 3.12 (td, <i>J</i> = 11.7, 3.5 Hz, 1H), 2.85–2.69 (m, 3H), 2.49 (dt, <i>J</i> = 14.1, 3.3 Hz, 1H), 1.40 (t, <i>J</i> = 6.9 Hz, 3H), 1.09 (d, <i>J</i> = 6.1 Hz, 3H). <i>m/z</i> obs 252.2 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-3-4" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> (<i>cis</i>)-1-(5-Ethoxy-2-fluorophenyl)-3-methylpiperidin-4-ol</h5><div class="NLM_p last">To a solution of 1-(5-ethoxy-2-fluorophenyl)-3-methylpiperidin-4-one (4.9 g, 20 mmol) in THF (98 mL) at −78 °C was added a 1 M solution of L-Selectride (23 mL, 23 mmol) in THF. After 1 h, the reaction mixture was quenched with 1 M aqueous NaOH (23 mL, 23 mmol) and warmed to 0 °C. Next, 30% aqueous H<sub>2</sub>O<sub>2</sub> (7.4 mL, 72 mmol) was added dropwise, and the reaction mixture was warmed to room temperature and stirred for 1 h. The reaction mixture was diluted with EtOAc/water, and the layers were separated. The aqueous layer was extracted with EtOAc (2×). The combined organic layers were washed with brine, dried (MgSO<sub>4</sub>), and concentrated. The crude product was purified by flash chromatography to provide (<i>cis</i>)-1-(5-ethoxy-2-fluorophenyl)-3-methylpiperidin-4-ol (4.4 g, 17 mmol, 90% yield) as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.89 (dd, <i>J</i> = 12.1, 8.8 Hz, 1H), 6.52 (dd, <i>J</i> = 7.3, 2.9 Hz, 1H), 6.37 (dt, <i>J</i> = 8.8, 3.2 Hz, 1H), 3.97 (q, <i>J</i> = 7.1 Hz, 2H), 3.90 (br s, 1H), 3.13–3.02 (m, 2H), 3.02–2.95 (m, 1H), 2.84 (dd, <i>J</i> = 11.4, 9.8 Hz, 1H), 2.05 (dqt, <i>J</i> = 10.1, 6.7, 3.6 Hz, 1H), 2.00–1.91 (m, 1H), 1.91–1.83 (m, 1H), 1.50 (br s, 1H), 1.38 (t, <i>J</i> = 6.9 Hz, 3H), 1.03 (d, <i>J</i> = 6.9 Hz, 3H). <i>m/z</i> obs 254.0 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-3-5" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> (3<i>R</i>,4<i>S</i>)-1-(5-Ethoxy-2-fluorophenyl)-3-methylpiperidin-4-ol</h5><div class="NLM_p last">(<i>cis</i>)-1-(5-Ethoxy-2-fluorophenyl)-3-methylpiperidin-4-ol (29 g, 120 mmol) was purified by chiral SFC to yield (3<i>R</i>,4<i>S</i>)-1-(5-ethoxy-2-fluorophenyl)-3-methylpiperidin-4-ol (13 g, 54 mmol, 47% yield) as a colorless oil after concentration. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.95 (dd, <i>J</i> = 12.1, 8.8 Hz, 1H), 6.52 (dd, <i>J</i> = 7.5, 2.9 Hz, 1H), 6.44 (dt, <i>J</i> = 8.8, 3.2 Hz, 1H), 3.98 (q, <i>J</i> = 7.3 Hz, 2H), 3.75–3.64 (m, 2H), 3.12 (td, <i>J</i> = 11.7, 3.5 Hz, 1H), 2.85–2.69 (m, 3H), 2.49 (dt, <i>J</i> = 14.1, 3.3 Hz, 1H), 1.40 (t, <i>J</i> = 6.9 Hz, 3H), 1.09 (d, <i>J</i> = 6.1 Hz, 3H). <i>m/z</i> obs 252.2 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-3-6" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Methyl 2-((4<i>S</i>,5<i>S</i>)-1-(4-(((3<i>R</i>,4<i>R</i>)-1-(5-Ethoxy-2-fluorophenyl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate</h5><div class="NLM_p last">To a solution of (3<i>R</i>,4<i>S</i>)-1-(5-ethoxy-2-fluorophenyl)-3-methylpiperidin-4-ol (2.5 g, 9.8 mmol), <b>14</b> (3.1 g, 10 mmol), and Bu<sub>3</sub>P (3.9 mL, 16 mmol) in toluene (120 mL) was added (<i>E</i>)-diazene-1,2-diylbis(piperidin-1-ylmethanone) (4.0 g, 16 mmol). The reaction mixture was sonicated for 2 h. The reaction mixture was poured into hexanes, and the resulting mixture was filtered. The crude product was purified by flash chromatography to provide methyl 2-((4<i>S</i>,5<i>S</i>)-1-(4-(((3<i>R</i>,4<i>R</i>)-1-(5-ethoxy-2-fluorophenyl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate (2.6 g, 4.7 mmol, 48% yield) as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.07–7.00 (m, 2H), 6.95–6.86 (m, 3H), 6.51 (dd, <i>J</i> = 7.3, 2.9 Hz, 1H), 6.39 (dt, <i>J</i> = 8.8, 3.0 Hz, 1H), 4.39 (dt, <i>J</i> = 10.1, 3.1 Hz, 1H), 3.98 (q, <i>J</i> = 7.0 Hz, 2H), 3.83 (td, <i>J</i> = 9.1, 4.3 Hz, 1H), 3.71 (s, 3H), 3.48–3.36 (m, 2H), 3.22–3.14 (m, 1H), 2.85–2.74 (m, 2H), 2.57 (dd, <i>J</i> = 12.1, 9.6 Hz, 1H), 2.41 (dd, <i>J</i> = 16.1, 10.3 Hz, 1H), 2.20–2.08 (m, 2H), 1.88–1.76 (m, 1H), 1.40 (t, <i>J</i> = 7.0 Hz, 3H), 1.34 (d, <i>J</i> = 7.2 Hz, 3H), 1.11 (d, <i>J</i> = 6.6 Hz, 3H). <i>m/z</i> obs 552.4 [M + H]<sup>+</sup>.</div></div><div id="sec8-1-3-7" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 2-((4<i>S</i>,5<i>S</i>)-1-(4-(((3<i>R</i>,4<i>R</i>)-1-(5-Ethoxy-2-fluorophenyl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetic acid (<b>33</b>)</h5><div class="NLM_p last">To a solution of methyl 2-((4<i>S</i>,5<i>S</i>)-1-(4-(((3<i>R</i>,4<i>R</i>)-1-(5-ethoxy-2-fluorophenyl)-3-methylpiperidin-4-yl)oxy)phenyl)-4-methyl-3-(trifluoromethyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)acetate (2.6 g, 4.7 mmol) in THF (85 mL) and water (8.5 mL) was added a 1 M aqueous solution of LiOH (58 mL, 23 mmol), and the reaction mixture was stirred at room temperature for 1 h until the reaction was deemed complete via HPLC analysis. The reaction mixture was concentrated to remove the THF, and hexanes and brine were added. The aqueous layers were acidified to pH 2 with 1 M aqueous HCl. The product was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), and the combined organic layers were dried (MgSO<sub>4</sub>) and concentrated to provide <b>33</b> (2.5 g, 4.6 mmol, 99% yield) as a white foam. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 7.99 (br s, 1H), 7.24 (ddd, <i>J</i> = 12.0, 9.3, 1.2 Hz, 1H), 7.12–7.04 (m, 2H), 7.02–6.93 (m, 3H), 4.47–4.38 (m, 1H), 4.18 (td, <i>J</i> = 10.0, 4.1 Hz, 1H), 4.04 (q, <i>J</i> = 6.9 Hz, 2H), 3.78–3.65 (m, 2H), 3.62 (dd, <i>J</i> = 12.4, 4.1 Hz, 1H), 3.42 (td, <i>J</i> = 11.8, 4.4 Hz, 1H), 3.37–3.27 (m, 1H), 2.83 (br s, 1H), 2.73 (dd, <i>J</i> = 16.5, 3.0 Hz, 1H), 2.54–2.38 (m, 2H), 2.36–2.28 (m, 1H), 1.37 (t, <i>J</i> = 7.0 Hz, 3H), 1.30 (d, <i>J</i> = 7.2 Hz, 3H), 1.11 (d, <i>J</i> = 6.9 Hz, 3H). <i>m/z</i> obs 538.3 [M + H]<sup>+</sup>. <sup>13</sup>C NMR (126 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 14.96, 15.22, 18.12, 28.86, 35.52, 35.75,45.94, 53.84, 59.20, 59.23, 65.56, 66.90, 111.32, 116.97, 117.18, 118.47, 118.60, 119.56 (d, <i>J</i> = 21.8 Hz), 123.03(q, J = 268.2 Hz), 131.12, 138.11, 141.90 (q, J = 34.7 Hz), 150.73 (d, J = 242.7 Hz), 153.66, 153.66, 156.63, 171.99. <sup>19</sup>F NMR (470 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm −63.86, −130.37. Optical rotation: [α]<sub class="stack">D</sub><sup class="stack">20</sup>: +17.07 (<i>c</i> 3.89, MeOH). HRMS (ESI/HESI) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>27</sub>H<sub>32</sub>F<sub>4</sub>N<sub>3</sub>O<sub>4</sub> 538.2323; Found 538.2312. Analytical HPLC (Orthogonal method) RT = 13.3 min, HI: 97%.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00982">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00982" class="ext-link">10.1021/acs.jmedchem.7b00982</a>. Full crystallographic data for compound <b>8</b> have been deposited to the Cambridge Crystallographic Data Center (CCDC reference no. 1559162) and can be obtained free of charge via the Internet at <a href="http://www.ccdc.cam.ac.uk" class="extLink">http://www.ccdc.cam.ac.uk</a>. <ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures for the synthesis of compounds <b>3b</b>–<b>35</b> and methods for <i>in vitro</i> and <i>in vivo</i> biological studies (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">X-ray crystallographic data for <b>8</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_002.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_001.pdf">jm7b00982_si_001.pdf (733.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_002.cif">jm7b00982_si_002.cif (21.48 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_003.csv">jm7b00982_si_003.csv (4.02 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00982" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Shi</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0810-3368" title="Orcid link">http://orcid.org/0000-0002-0810-3368</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#254f504b0b564d4c654748560b464a48"><span class="__cf_email__" data-cfemail="3a504f54144952537a58574914595557">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhengxiang Gu</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Anne Jurica</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3689-5451" title="Orcid link">http://orcid.org/0000-0003-3689-5451</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ximao Wu</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lauren E. Haque</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin N. Williams</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andres S. Hernandez</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenqiu Hong</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Gao</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marta Dabros</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akin H. Davulcu</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arvind Mathur</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard A. Rampulla</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arun Kumar Gupta</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramya Jayaram</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atsu Apedo</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas B. Moore</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heng Liu</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lori K. Kunselman</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward J. Brady</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason J. Wilkes</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bradley A. Zinker</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Cai</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yue-Zhong Shu</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qin Sun</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth A. Dierks</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly A. Foster</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carrie Xu</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Wang</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reshma Panemangalore</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Ellen Cvijic</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunshan Xie</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary G. Cao</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Zhou</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Krupinski</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean M. Whaley</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey A. Robl</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William R. Ewing</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce Alan Ellsworth</span> - <span class="hlFld-Affiliation affiliation">Research and Development, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, New Jersey 08540-4000, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the GPR40 team at both Bristol-Myers Squibb and Biocon Bristol-Myers Squibb Research Center for their efforts and dedication. We thank Dr. James R. Corte and Dr. Peter T. Cheng for their assistance in manuscript preparation.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i50" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i50"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="DEF-LIST-d94e4300-autogenerated"><div id="ac_i51" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i51"> Abbreviations Used</h2><tr><td class="NLM_term">GPR40</td><td class="NLM_def"><p class="first last">G protein-coupled receptor 40</p></td></tr><tr><td class="NLM_term">T2DM</td><td class="NLM_def"><p class="first last">type 2 diabetes mellitus</p></td></tr><tr><td class="NLM_term">GSIS</td><td class="NLM_def"><p class="first last">glucose-stimulated insulin secretion</p></td></tr><tr><td class="NLM_term">GIP</td><td class="NLM_def"><p class="first last">glucose-dependent insulintropic peptide</p></td></tr><tr><td class="NLM_term">PPARγ</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor γ</p></td></tr><tr><td class="NLM_term">FFAR1</td><td class="NLM_def"><p class="first last">free fatty acid receptor 1</p></td></tr><tr><td class="NLM_term">FFAs</td><td class="NLM_def"><p class="first last">free fatty acids</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">docosahexaenoic acid</p></td></tr><tr><td class="NLM_term">LA</td><td class="NLM_def"><p class="first last">linoleic acid</p></td></tr><tr><td class="NLM_term">DPP4 inhibitor</td><td class="NLM_def"><p class="first last">dipeptidylpeptidase-4 inhibitor</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoroacetic anhydride</p></td></tr><tr><td class="NLM_term">MsCl</td><td class="NLM_def"><p class="first last">methanesulfonyl chloride</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N,N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">TsCl</td><td class="NLM_def"><p class="first last"><i>p</i>-toluenesulfonyl chloride</p></td></tr><tr><td class="NLM_term">S-phos precatalyst</td><td class="NLM_def"><p class="first last">chloro(2-dicyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl)(2′-amino-1,1′-biphenyl-2-yl)palladium(II)</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsily</p></td></tr><tr><td class="NLM_term">ADDP</td><td class="NLM_def"><p class="first last">1,1′-(azodicarbonyl)dipiperidine</p></td></tr><tr><td class="NLM_term">TMEDA</td><td class="NLM_def"><p class="first last">tetramethylethylenediamine</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">IPGTT</td><td class="NLM_def"><p class="first last">intraperitoneal glucose tolerance test</p></td></tr><tr><td class="NLM_term">oGTT</td><td class="NLM_def"><p class="first last">oral glucose tolerance test</p></td></tr><tr><td class="NLM_term">Xphos</td><td class="NLM_def"><p class="first last">2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04757" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04757" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Rotenstein, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozak, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shivers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarchoan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Close, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Close, K. L.</span><span> </span><span class="NLM_article-title">The ideal diabetes therapy: what will it look like? how close are we?</span> <span class="citation_source-journal">Clinical Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.2337/diaclin.30.2.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.2337%2Fdiaclin.30.2.44" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=44-53&author=L.+S.+Rotensteinauthor=B.+M.+Kozakauthor=J.+P.+Shiversauthor=M.+Yarchoanauthor=J.+Closeauthor=K.+L.+Close&title=The+ideal+diabetes+therapy%3A+what+will+it+look+like%3F+how+close+are+we%3F&doi=10.2337%2Fdiaclin.30.2.44"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2337%2Fdiaclin.30.2.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiaclin.30.2.44%26sid%3Dliteratum%253Aachs%26aulast%3DRotenstein%26aufirst%3DL.%2BS.%26aulast%3DKozak%26aufirst%3DB.%2BM.%26aulast%3DShivers%26aufirst%3DJ.%2BP.%26aulast%3DYarchoan%26aufirst%3DM.%26aulast%3DClose%26aufirst%3DJ.%26aulast%3DClose%26aufirst%3DK.%2BL.%26atitle%3DThe%2520ideal%2520diabetes%2520therapy%253A%2520what%2520will%2520it%2520look%2520like%253F%2520how%2520close%2520are%2520we%253F%26jtitle%3DClinical%2520Diabetes%26date%3D2012%26volume%3D30%26spage%3D44%26epage%3D53%26doi%3D10.2337%2Fdiaclin.30.2.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span> </span><span class="NLM_article-title">World health organization diabetes fact sheet 2013</span>, <a href="http://www.who.int/mediacentre/factsheets/fs312/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs312/en/</a> (accessed on Feb 29, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+health+organization+diabetes+fact+sheet+2013%2C+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs312%2Fen%2F+%28accessed+on+Feb+29%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DWorld%2520health%2520organization%2520diabetes%2520fact%2520sheet%25202013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">International diabetes federation</span>. <span> </span><span class="NLM_article-title">Diabetes Atlas</span>, 8th ed., 2017, <a href="http://www.diabetesatlas.org/resources/2017-atlas.html" class="extLink">http://www.diabetesatlas.org/resources/2017-atlas.html</a> (accessed Dec 11, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=International+diabetes+federation.+Diabetes+Atlas%2C+8th+ed.%2C+2017%2C+http%3A%2F%2Fwww.diabetesatlas.org%2Fresources%2F2017-atlas.html+%28accessed+Dec+11%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DDiabetes%2520Atlas" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span> </span><span class="NLM_article-title">Standards of medical care in diabetes—2015: summary of revisions</span>.  <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S4</span>.<span class="refDoi"> DOI: 10.2337/dc15-S003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.2337%2Fdc15-S003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Standards+of+medical+care+in+diabetes%E2%80%942015%3A+summary+of+revisions.+Diabetes+Care+2015%2C+38+%28Suppl.+1%29%2C+S4.+10.2337%2Fdc15-S003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2337%2Fdc15-S003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdc15-S003%26sid%3Dliteratum%253Aachs%26atitle%3DStandards%2520of%2520medical%2520care%2520in%2520diabetes%25E2%2580%25942015%253A%2520summary%2520of%2520revisions%26jtitle%3DDiabetes%2520Care%26date%3D2015%26volume%3D38%26issue%3DSuppl.%25201%26spage%3DS4%26doi%3D10.2337%2Fdc15-S003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilsboll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">The incretin system and its role in type 2 diabetes mellitus</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.mce.2008.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.mce.2008.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=18786605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=127-136&author=J.+J.+Holstauthor=T.+Vilsbollauthor=C.+F.+Deacon&title=The+incretin+system+and+its+role+in+type+2+diabetes+mellitus&doi=10.1016%2Fj.mce.2008.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The incretin system and its role in type 2 diabetes mellitus</span></div><div class="casAuthors">Holst, Jens Juul; Vilsboell, Tina; Deacon, Carolyn F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The incretin hormones are released during meals from gut endocrine cells.  They potentiate glucose-induced insulin secretion and may be responsible for up to 70% of postprandial insulin secretion.  The incretin hormones include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), both of which may also promote proliferation/neogenesis of beta cells and prevent their decay (apoptosis).  Both hormones contribute to insulin secretion from the beginning of a meal and their effects are progressively amplified as plasma glucose concns. rise.  The current interest in the incretin hormones is due to the fact that the incretin effect is severely reduced or absent in patients with type 2 diabetes mellitus (T2DM).  In addn., there is hyperglucagonemia, which is not suppressible by glucose.  In such patients, the secretion of GIP is near normal, but its effect on insulin secretion, particularly the late phase, is severely impaired.  The loss of GIP action is probably a consequence of diabetes, since it is also obsd. in patients with diabetes secondary to chronic pancreatitis, in whom the incretin effect is also lost.  GLP-1 secretion, on the other hand, is also impaired, but its insulinotropic and glucagon-suppressive actions are preserved, although the potency of GLP-1 in this respect is decreased compared to healthy subjects.  However, in supraphysiol. doses, GLP-1 administration may completely normalize beta as well as alpha cell sensitivity to glucose.  The impaired action of GLP-1 and GIP in T2DM may be at least partly restored by improved glycemic control, as shown in studies involving 4 wk of intensive insulin therapy.  The reduced incretin effect is believed to contribute to impaired regulation of insulin and glucagon secretion in T2DM, and, in support of this, exogenous GLP-1 administration may restore blood glucose regulation to near normal levels.  Thus, the pathogenesis of T2DM seems to involve a dysfunction of both incretins.  Enhancement of incretin action may therefore represent a therapeutic soln.  Clin. strategies therefore include the development of metabolically stable activators of the GLP-1 receptor; and inhibition of DPP-4, the enzyme that destroys native GLP-1 almost immediately.  Orally active DPP-4 inhibitors and the metabolically stable activators, exenatide (Byetta), are now on the market, and numerous clin. studies have shown that both principles are assocd. with durable antidiabetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEt5VBmX7VnLVg90H21EOLACvtfcHk0liZbDFKbCQ1gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73P&md5=5995635fd35fb982d0b8740353f86dc3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2008.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2008.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DVilsboll%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DThe%2520incretin%2520system%2520and%2520its%2520role%2520in%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2009%26volume%3D297%26spage%3D127%26epage%3D136%26doi%3D10.1016%2Fj.mce.2008.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drucker, D. J.</span><span> </span><span class="NLM_article-title">Pharmacology, physiology, and mechanisms of incretin hormone action</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.1016/j.cmet.2013.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.cmet.2013.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=23684623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=819-837&author=J.+E.+Campbellauthor=D.+J.+Drucker&title=Pharmacology%2C+physiology%2C+and+mechanisms+of+incretin+hormone+action&doi=10.1016%2Fj.cmet.2013.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action</span></div><div class="casAuthors">Campbell, Jonathan E.; Drucker, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">819-837</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Incretin peptides, principally GLP-1 and GIP, regulate islet hormone secretion, glucose concns., lipid metab., gut motility, appetite and body wt., and immune function, providing a scientific basis for utilizing incretin-based therapies in the treatment of type 2 diabetes.  Activation of GLP-1 and GIP receptors also leads to nonglycemic effects in multiple tissues, through direct actions on tissues expressing incretin receptors and indirect mechanisms mediated through neuronal and endocrine pathways.  Here we contrast the pharmacol. and physiol. of incretin hormones and review recent advances in mechanisms coupling incretin receptor signaling to pleiotropic metabolic actions in preclin. studies.  We discuss whether mechanisms identified in preclin. studies have potential translational relevance for the treatment of human disease and highlight controversies and uncertainties in incretin biol. that require resoln. in future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRNiGuKdmu97Vg90H21EOLACvtfcHk0liZbDFKbCQ1gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGktbs%253D&md5=8a82721ed5d7542784f27ca95c62a694</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2013.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2013.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DPharmacology%252C%2520physiology%252C%2520and%2520mechanisms%2520of%2520incretin%2520hormone%2520action%26jtitle%3DCell%2520Metab.%26date%3D2013%26volume%3D17%26spage%3D819%26epage%3D837%26doi%3D10.1016%2Fj.cmet.2013.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">U.S. Food and Drug Administration</span>. <span> </span><span class="NLM_article-title">Guidance for Industry Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention</span>, Appendix A, <a href="https://www.fda.gov/downloads/Drugs/.../Guidances/ucm071624.pdf" class="extLink">https://www.fda.gov/downloads/Drugs/.../Guidances/ucm071624.pdf</a> (accessed Aug 14, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+Food+and+Drug+Administration.+Guidance+for+Industry+Diabetes+Mellitus%3A+Developing+Drugs+and+Therapeutic+Biologics+for+Treatment+and+Prevention%2C+Appendix+A%2C+https%3A%2F%2Fwww.fda.gov%2Fdownloads%2FDrugs%2F...%2FGuidances%2Fucm071624.pdf+%28accessed+Aug+14%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DGuidance%2520for%2520Industry%2520Diabetes%2520Mellitus%253A%2520Developing%2520Drugs%2520and%2520Therapeutic%2520Biologics%2520for%2520Treatment%2520and%2520Prevention" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Khan, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L.</span><span> </span><span class="NLM_article-title">The role of polyunsaturated fatty acids and GPR40 receptor in brain</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.neuropharm.2015.05.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=639-651&author=M.+Z.+Khanauthor=L.+He&title=The+role+of+polyunsaturated+fatty+acids+and+GPR40+receptor+in+brain&doi=10.1016%2Fj.neuropharm.2015.05.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BZ.%26aulast%3DHe%26aufirst%3DL.%26atitle%3DThe%2520role%2520of%2520polyunsaturated%2520fatty%2520acids%2520and%2520GPR40%2520receptor%2520in%2520brain%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D113%26spage%3D639%26epage%3D651%26doi%3D10.1016%2Fj.neuropharm.2015.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y. Q.</span><span> </span><span class="NLM_article-title">GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5603</span><span class="NLM_x">–</span> <span class="NLM_lpage">5612</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.bmcl.2016.10.074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5603-5612&author=C.+Chenauthor=H.+Liauthor=Y.+Q.+Long&title=GPR40+agonists+for+the+treatment+of+type+2+diabetes+mellitus%3A+The+biological+characteristics+and+the+chemical+space&doi=10.1016%2Fj.bmcl.2016.10.074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DGPR40%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%253A%2520The%2520biological%2520characteristics%2520and%2520the%2520chemical%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5603%26epage%3D5612%26doi%3D10.1016%2Fj.bmcl.2016.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hara, T.</span><span> </span><span class="NLM_article-title">Ligands at Free Fatty Acid Receptor 1 (GPR40)</span>. In  <span class="citation_source-book">Handbook of Experimental Pharmacology</span>; <span class="NLM_contrib-group">Milligan, G.; Kimura, I.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1007%2F164_2016_59" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=1-16&author=T.+Haraauthor=G.+Milligan&author=I.+Kimura&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F164_2016_59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F164_2016_59%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DT.%26atitle%3DLigands%2520at%2520Free%2520Fatty%2520Acid%2520Receptor%25201%2520%2528GPR40%2529%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DMilligan%26aufirst%3DG.%26pub%3DSpringer%26date%3D2016%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Morgan, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhayal, S.</span><span> </span><span class="NLM_article-title">G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span><span class="refDoi"> DOI: 10.1016/j.bcp.2009.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.bcp.2009.07.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=1419-1427&author=N.+G.+Morganauthor=S.+Dhayal&title=G-protein+coupled+receptors+mediating+long+chain+fatty+acid+signalling+in+the+pancreatic+beta-cell&doi=10.1016%2Fj.bcp.2009.07.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DN.%2BG.%26aulast%3DDhayal%26aufirst%3DS.%26atitle%3DG-protein%2520coupled%2520receptors%2520mediating%2520long%2520chain%2520fatty%2520acid%2520signalling%2520in%2520the%2520pancreatic%2520beta-cell%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D1419%26epage%3D1427%26doi%3D10.1016%2Fj.bcp.2009.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Edfalk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steneberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, H.</span><span> </span><span class="NLM_article-title">GPR40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2280</span><span class="NLM_x">–</span> <span class="NLM_lpage">2287</span><span class="refDoi"> DOI: 10.2337/db08-0307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.2337%2Fdb08-0307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=18519800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=2280-2287&author=S.+Edfalkauthor=P.+Stenebergauthor=H.+Edlund&title=GPR40+is+expressed+in+enteroendocrine+cells+and+mediates+free+fatty+acid+stimulation+of+incretin+secretion&doi=10.2337%2Fdb08-0307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion</span></div><div class="casAuthors">Edfalk, Sara; Steneberg, Paer; Edlund, Helena</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2280-2287</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Objective-The G-protein-coupled receptor Gpr40 is expressed in β-cells where it contributes to free fatty acid (FFA) enhancement of glucose-stimulated insulin secretion.  However, other sites of Gpr40 expression, including the intestine, have been suggested.  The transcription factor IPF1/PDX1 was recently shown to bind to an enhancer element within the 5'-flanking region of Gpr40, implying that IPF1/PDX1 might regulate Gpr40 expression.  Here, we addressed whether (1) Gpr40 is expressed in the intestine and (2) Ipf1/Pdx1 function is required for Gpr40 expression.  Research Design and Methods-In the present study, Gpr40 expression was monitored by X-gal staining using Gpr40 reporter mice and by in situ hybridization.  Ipf1/Pdx1-null and β-cell specific mutants were used to investigate whether Ipf1/Pdx1 controls Gpr40 expression.  Plasma insulin, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucose levels in response to acute oral fat diet were detd. in Gpr40 mutant and control mice.  Results-Here, we show that Gpr40 is expressed in endocrine cells of the gastrointestinal tract, including cells expressing the incretin hormones GLP-1 and GIP, and that Gpr40 mediates FFA-stimulated incretin secretion.  We also show that Ipf1/Pdx1 is required for expression of Gpr40 in β-cells and endocrine cells of the anterior gastrointestinal tract.  Conclusions-Together, our data provide evidence that Gpr40 modulates FFA-stimulated insulin secretion from β-cells not only directly but also indirectly via regulation of incretin secretion.  Moreover, our data suggest a conserved role for Ipf1/Pdx1 and Gpr40 in FFA-mediated secretion of hormones that regulate glucose and overall energy homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAqbrs6Tw1bVg90H21EOLACvtfcHk0ljtC4WnlxIE6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrtrvP&md5=5263b80283b86beb0eba5c41d1c25bb0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2337%2Fdb08-0307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb08-0307%26sid%3Dliteratum%253Aachs%26aulast%3DEdfalk%26aufirst%3DS.%26aulast%3DSteneberg%26aufirst%3DP.%26aulast%3DEdlund%26aufirst%3DH.%26atitle%3DGPR40%2520is%2520expressed%2520in%2520enteroendocrine%2520cells%2520and%2520mediates%2520free%2520fatty%2520acid%2520stimulation%2520of%2520incretin%2520secretion%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D2280%26epage%3D2287%26doi%3D10.2337%2Fdb08-0307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hauge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestmar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husted, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinglass, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelstoft, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo</span> <span class="citation_source-journal">Mol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1016/j.molmet.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.molmet.2014.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=25685685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCku7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=3-14&author=M.+Haugeauthor=M.+A.+Vestmarauthor=A.+S.+Hustedauthor=J.+P.+Ekbergauthor=M.+J.+Wrightauthor=J.+Di+Salvoauthor=A.+B.+Weinglassauthor=M.+S.+Engelstoftauthor=A.+N.+Madsenauthor=M.+Luckmannauthor=M.+W.+Millerauthor=M.+E.+Trujilloauthor=T.+M.+Frimurerauthor=B.+Holstauthor=A.+D.+Howardauthor=T.+W.+Schwartz&title=GPR40+%28FFAR1%29+-+Combined+Gs+and+Gq+signaling+in+vitro+is+associated+with+robust+incretin+secretagogue+action+ex+vivo+and+in+vivo&doi=10.1016%2Fj.molmet.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo</span></div><div class="casAuthors">Hauge, Maria; Vestmar, Marie A.; Husted, Anna S.; Ekberg, Jeppe P.; Wright, Michael J.; Di Salvo, Jerry; Weinglass, Adam B.; Engelstoft, Maja S.; Madsen, Andreas N.; Luckmann, Michael; Miller, Michael W.; Trujillo, Maria E.; Frimurer, Thomas M.; Holst, Birgitte; Howard, Andrew D.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">GPR40 (FFAR1), a clin. proven anti-diabetes target, is a Gq-coupled receptor for long chain fatty acids (LCFA) stimulating insulin secretion directly and mediating a major part of the dietary triglyceride-induced secretion of the incretins GLP-1 and GIP.  In phase-II studies the GPR40 agonist TAK-875 decreased blood glucose but surprisingly without stimulating incretins.  Here we find that GPR40 can signal through not only Gq and IP3 but also Gs and cAMP when stimulated with certain agonists such as AM-1638 and AM-5262 in contrast to the endogenous LCFA ligands and agonists such as TAK-875 and AM-837, which only signal through Gq.  In competition binding against [3H]AM-1638 and [3H]L358 the Gq + Gs and the Gq-only agonists either competed for or showed pos. cooperativity by increasing the binding of the two different radio-ligands, in opposite ways.  Nevertheless, both the Gq-only and the Gq + Gs agonists all docked surprisingly well into the binding site for TAK-875 in the X-ray structure of GPR40.  In murine intestinal primary cell-cultures the endogenous LCFAs and the Gq-only agonists stimulated GLP-1 secretion with rather poor efficacy as compared with the high efficacy Gq + Gs GPR40 agonists and a prototype GPR119 agonist.  Similarly, in fasting both male and female mice the Gq + Gs agonists showed significantly higher efficacy than the Gq-only agonists in respect of increasing plasma GLP-1 and plasma GIP in a GPR40-dependent manner.  It is concluded that stimulation of GPR40 by endogenous LCFAs or by Gq-only synthetic agonists result in a rather limited incretin response, whereas Gq + Gs GPR40 agonists stimulate incretin secretion robustly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZyjcjTNd0QbVg90H21EOLACvtfcHk0ljtC4WnlxIE6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCku7bN&md5=895136bef8c9542711e6daf5fa57219c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DHauge%26aufirst%3DM.%26aulast%3DVestmar%26aufirst%3DM.%2BA.%26aulast%3DHusted%26aufirst%3DA.%2BS.%26aulast%3DEkberg%26aufirst%3DJ.%2BP.%26aulast%3DWright%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DWeinglass%26aufirst%3DA.%2BB.%26aulast%3DEngelstoft%26aufirst%3DM.%2BS.%26aulast%3DMadsen%26aufirst%3DA.%2BN.%26aulast%3DLuckmann%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DM.%2BW.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DGPR40%2520%2528FFAR1%2529%2520-%2520Combined%2520Gs%2520and%2520Gq%2520signaling%2520in%2520vitro%2520is%2520associated%2520with%2520robust%2520incretin%2520secretagogue%2520action%2520ex%2520vivo%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Metab.%26date%3D2015%26volume%3D4%26spage%3D3%26epage%3D14%26doi%3D10.1016%2Fj.molmet.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span> </span><span class="NLM_article-title">A potent class of GPR40 full agonists engages the enteroInsular axis to promote glucose control in rodents</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e463000</span><span class="NLM_x">–</span> <span class="NLM_lpage">e463012</span><span class="refDoi"> DOI: 10.1371/journal.pone.0046300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1371%2Fjournal.pone.0046300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e463000-e463012&author=J.+Luoauthor=G.+Swaminathauthor=S.+P.+Brownauthor=J.+Zhangauthor=Q.+Guoauthor=M.+Chenauthor=K.+Nguyenauthor=T.+Tranauthor=L.+Miaoauthor=P.+Dransfieldauthor=M.+Vimolratanaauthor=J.+Houzeauthor=S.+Wongauthor=M.+Totevaauthor=B.+Shanauthor=F.+Liauthor=R.+Zhuangauthor=D.+C.+H.+Lin&title=A+potent+class+of+GPR40+full+agonists+engages+the+enteroInsular+axis+to+promote+glucose+control+in+rodents&doi=10.1371%2Fjournal.pone.0046300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0046300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0046300%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DDransfield%26aufirst%3DP.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26atitle%3DA%2520potent%2520class%2520of%2520GPR40%2520full%2520agonists%2520engages%2520the%2520enteroInsular%2520axis%2520to%2520promote%2520glucose%2520control%2520in%2520rodents%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De463000%26epage%3De463012%26doi%3D10.1371%2Fjournal.pone.0046300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattaropong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, B.</span><span> </span><span class="NLM_article-title">J. Discovery of AM-1638: a potent and orally bioavailable GPR40/FFA1 full agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1021/ml300133f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300133f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=726-730&author=S.+P.+Brownauthor=P.+J.+Dransfieldauthor=M.+Vimolratanaauthor=X.+Y.+Jiaoauthor=L.+Zhuauthor=V.+Pattaropongauthor=Y.+Sunauthor=J.+Liuauthor=J.+Luoauthor=J.+Zhangauthor=S.+Wongauthor=R.+Zhuangauthor=Q.+Guoauthor=F.+Liauthor=J.+C.+Medinaauthor=G.+Swaminathauthor=D.+C.-H.+Linauthor=B.+Houze&title=J.+Discovery+of+AM-1638%3A+a+potent+and+orally+bioavailable+GPR40%2FFFA1+full+agonist&doi=10.1021%2Fml300133f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml300133f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300133f%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%2BC.-H.%26aulast%3DHouze%26aufirst%3DB.%26atitle%3DJ.%2520Discovery%2520of%2520AM-1638%253A%2520a%2520potent%2520and%2520orally%2520bioavailable%2520GPR40%252FFFA1%2520full%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D726%26epage%3D730%26doi%3D10.1021%2Fml300133f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jurica, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampulla, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunselman, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnur, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierks, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvijic, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panemangalore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, B. A.</span><span> </span><span class="NLM_article-title">Discovery of pyrrolidine-containing GPR40 agonists: stereochemistry effects a change in binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1431</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01559</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01559" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1417-1431&author=E.+A.+Juricaauthor=X.+Wuauthor=K.+N.+Williamsauthor=A.+S.+Hernandezauthor=D.+S.+Nirschlauthor=R.+A.+Rampullaauthor=A.+Mathurauthor=M.+Zhouauthor=G.+Caoauthor=C.+Xieauthor=B.+Jacobauthor=H.+Caiauthor=T.+Wangauthor=B.+J.+Murphyauthor=H.+Liuauthor=C.+Xuauthor=L.+K.+Kunselmanauthor=M.+B.+Hicksauthor=Q.+Sunauthor=D.+M.+Schnurauthor=E.+A.+Dierksauthor=A.+Apedoauthor=D.+B.+Mooreauthor=K.+A.+Fosterauthor=M.+E.+Cvijicauthor=R.+Panemangaloreauthor=N.+A.+Flynnauthor=B.+D.+Maxwellauthor=Y.+Hongauthor=Y.+Tianauthor=J.+J.+Wilkesauthor=B.+A.+Zinkerauthor=J.+M.+Whaleyauthor=J.+C.+Barrishauthor=J.+A.+Roblauthor=W.+R.+Ewingauthor=B.+A.+Ellsworth&title=Discovery+of+pyrrolidine-containing+GPR40+agonists%3A+stereochemistry+effects+a+change+in+binding+mode&doi=10.1021%2Facs.jmedchem.6b01559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01559%26sid%3Dliteratum%253Aachs%26aulast%3DJurica%26aufirst%3DE.%2BA.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWilliams%26aufirst%3DK.%2BN.%26aulast%3DHernandez%26aufirst%3DA.%2BS.%26aulast%3DNirschl%26aufirst%3DD.%2BS.%26aulast%3DRampulla%26aufirst%3DR.%2BA.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DJacob%26aufirst%3DB.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DB.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DKunselman%26aufirst%3DL.%2BK.%26aulast%3DHicks%26aufirst%3DM.%2BB.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DSchnur%26aufirst%3DD.%2BM.%26aulast%3DDierks%26aufirst%3DE.%2BA.%26aulast%3DApedo%26aufirst%3DA.%26aulast%3DMoore%26aufirst%3DD.%2BB.%26aulast%3DFoster%26aufirst%3DK.%2BA.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DPanemangalore%26aufirst%3DR.%26aulast%3DFlynn%26aufirst%3DN.%2BA.%26aulast%3DMaxwell%26aufirst%3DB.%2BD.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DWilkes%26aufirst%3DJ.%2BJ.%26aulast%3DZinker%26aufirst%3DB.%2BA.%26aulast%3DWhaley%26aufirst%3DJ.%2BM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520of%2520pyrrolidine-containing%2520GPR40%2520agonists%253A%2520stereochemistry%2520effects%2520a%2520change%2520in%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1417%26epage%3D1431%26doi%3D10.1021%2Facs.jmedchem.6b01559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ellsworth, B. A.; Shi, J.; Jurica, E. A.; Nielsen, L. L.; Wu, X.; Hernandez, A. S.; Wang, Y.; Gu, Z.; Williams, K. N.; Chen, B.; Cherney, E. C.; Ye, X.-Y.; Wang, Y.; Zhou, M.; Cao, G.; Xie, C.; Wilkes, J. J.; Liu, H.; Kunselman, L. K.; Gupta, A. K.; Jayarama, R.; Ramar, T.; Rao, P.; Zinker, B. A.; Sun, Q.; Dierks, E. A.; Foster, K. A.; Wang, T.; Cviji, M. E.; Whaley, J. M.; Robl, J. A.; Ewing, W. R.</span><span> </span><span class="NLM_article-title">Discovery of BMS-986118, a dual MOA GPR40 agonist that produces glucose-dependent insulin and GLP-1 secretion</span>. Presented at the 248th ACS National Meeting, San Francisco, CA, Aug 10–14,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>MEDI031.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+A.+Ellsworth&author=J.+Shi&author=E.+A.+Jurica&author=L.+L.+Nielsen&author=X.+Wu&author=A.+S.+Hernandez&author=Y.+Wang&author=Z.+Gu&author=K.+N.+Williams&author=B.+Chen&author=E.+C.+Cherney&author=X.-Y.+Ye&author=Y.+Wang&author=M.+Zhou&author=G.+Cao&author=C.+Xie&author=J.+J.+Wilkes&author=H.+Liu&author=L.+K.+Kunselman&author=A.+K.+Gupta&author=R.+Jayarama&author=T.+Ramar&author=P.+Rao&author=B.+A.+Zinker&author=Q.+Sun&author=E.+A.+Dierks&author=K.+A.+Foster&author=T.+Wang&author=M.+E.+Cviji&author=J.+M.+Whaley&author=J.+A.+Robl&author=W.+R.+Ewing&title=Discovery+of+BMS-986118%2C+a+dual+MOA+GPR40+agonist+that+produces+glucose-dependent+insulin+and+GLP-1+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520of%2520BMS-986118%252C%2520a%2520dual%2520MOA%2520GPR40%2520agonist%2520that%2520produces%2520glucose-dependent%2520insulin%2520and%2520GLP-1%2520secretion%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">Compound <b>1</b> produced an increase in locomotor activity at a dose of 80 mg/kg (plasma concentration, Cmax = 333 uM) in a study in telemeterized mice. Compound <b>2</b> produced a increase of heart rate by 20 bpm a study of telemeterized cynomologous monkeys at a dose of 180 mg/kg (plasma concentration, <i>C</i><sub>max</sub> = 33–39 μM).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span> </span><span class="NLM_article-title">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span><span class="refDoi"> DOI: 10.1517/17425250903042318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1517%2F17425250903042318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=19519283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=921-931&author=D.+A.+Priceauthor=J.+Blaggauthor=L.+Jonesauthor=N.+Greeneauthor=T.+Wager&title=Physicochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes%3A+a+review&doi=10.1517%2F17425250903042318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span></div><div class="casAuthors">Price, David A.; Blagg, Julian; Jones, Lyn; Greene, Nigel; Wager, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-931</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The genesis of any toxicol. or safety outcome is multifactorial and complex; for this reason, it can be difficult for drug discovery projects to factor the avoidance of toxicity outcomes into their target design.  A focus on readily measurable parameters from high-throughput in vitro assays (e.g., primary potency, clearance) is easier to handle and have become the mainstays of drug discovery projects.  However, the fundamental origins of adverse safety or toxicity findings can be considered as deriving from four parameters, all of which are in the control of the drug designer.  These can be described as primary pharmacol., off target pharmacol., the presence of a defined structural fragment that can be assocd. with adverse outcomes and the overall physicochem. properties of the mol. that may predispose it to adverse outcomes.  In the drug discovery community, there has been recognition for many years of the influence of physicochem. drug properties (in particular lipophilicity) on the toxicol. profile of compds., and recent research is now beginning to quantify that risk in a probabilistic sense.  This review focuses on the overall properties of classes of mols. that are assocd. with an increased probability of adverse outcomes in in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8kwwUsaFIrVg90H21EOLACvtfcHk0lhOVFf8evuWNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D&md5=bd1cca3634afda14de2f8aa115d7d55e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F17425250903042318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903042318%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DWager%26aufirst%3DT.%26atitle%3DPhysicochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%253A%2520a%2520review%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D921%26epage%3D931%26doi%3D10.1517%2F17425250903042318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhOVFf8evuWNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Garanti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilati, T.</span><span> </span><span class="NLM_article-title">Diastereoselective cycloadditions of nitrilimines to enantiopure acrylamides</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span><span class="refDoi"> DOI: 10.1016/S0957-4166(02)00258-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2FS0957-4166%2802%2900258-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=1285-1289&author=L.+Garantiauthor=G.+Molteniauthor=T.+Pilati&title=Diastereoselective+cycloadditions+of+nitrilimines+to+enantiopure+acrylamides&doi=10.1016%2FS0957-4166%2802%2900258-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2802%2900258-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252802%252900258-6%26sid%3Dliteratum%253Aachs%26aulast%3DGaranti%26aufirst%3DL.%26aulast%3DMolteni%26aufirst%3DG.%26aulast%3DPilati%26aufirst%3DT.%26atitle%3DDiastereoselective%2520cycloadditions%2520of%2520nitrilimines%2520to%2520enantiopure%2520acrylamides%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2002%26volume%3D13%26spage%3D1285%26epage%3D1289%26doi%3D10.1016%2FS0957-4166%2802%2900258-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaura, N.</span><span> </span><span class="NLM_article-title">Palladium(0)-catalyzed cross-coupling reaction of alkoxydiboron with haloarenes: a direct procedure for arylboronic esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7508</span><span class="NLM_x">–</span> <span class="NLM_lpage">7510</span><span class="refDoi"> DOI: 10.1021/jo00128a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-catalyzed+cross-coupling+reaction+of+alkoxydiboron+with+haloarenes%3A+a+direct+procedure+for+arylboronic+esters&doi=10.1021%2Fjo00128a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0ljiBJ39eSi2Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520cross-coupling%2520reaction%2520of%2520alkoxydiboron%2520with%2520haloarenes%253A%2520a%2520direct%2520procedure%2520for%2520arylboronic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510%26doi%3D10.1021%2Fjo00128a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Uetrecht, J.</span><span> </span><span class="NLM_article-title">Idiosyncratic drug reactions: past, present, and future</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1021/tx700186p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700186p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlygsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=84-92&author=J.+Uetrecht&title=Idiosyncratic+drug+reactions%3A+past%2C+present%2C+and+future&doi=10.1021%2Ftx700186p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Idiosyncratic Drug Reactions: Past, Present, and Future</span></div><div class="casAuthors">Uetrecht, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-92</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although the major working hypothesis for the mechanism of idiosyncratic drug reactions (IDRs), the hapten hypothesis, has not changed since 1987, several hypotheses have been added, for example, the danger hypothesis and the pharmaceutical interaction hypothesis.  Genetic studies have found that several IDRs are linked to specific HLA genes, providing addnl. evidence that they are immune-mediated.  Evidence that most IDRs are caused by reactive metabolites has led pharmaceutical companies to avoid drug candidates that form significant amts. of reactive metabolites; however, at least one IDR, ximelagatran-induced liver toxicity, does not appear to be caused by a reactive metabolite.  It is possible that there are biomarkers such as those related to cell stress that would predict that a drug candidate would cause a significant incidence of IDRs; however, there has been no systematic study of the changes in gene expression induced by drugs known to cause IDRs.  A major impediment to the study of the mechanisms of IDRs is the paucity of valid animal models, and if we had a better mechanistic understanding, it should be easier to develop such models.  There is growing evidence that these adverse reactions are more varied and complex than previously recognized, and it is unlikely that a quick fix will be achieved.  However, IDRs are an important cause of patient morbidity and mortality and markedly increase the uncertainty of drug development; therefore, continued basic research in this area is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLG5_bNuaw4LVg90H21EOLACvtfcHk0ljiBJ39eSi2Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlygsr%252FN&md5=eaed35d895118a05034c7762efd060dc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Ftx700186p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700186p%26sid%3Dliteratum%253Aachs%26aulast%3DUetrecht%26aufirst%3DJ.%26atitle%3DIdiosyncratic%2520drug%2520reactions%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D84%26epage%3D92%26doi%3D10.1021%2Ftx700186p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gungor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusarchyk, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6476</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.bmcl.2007.09.090" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6476-6480&author=L.+M.+Simpkinsauthor=S.+Boltonauthor=Z.+Piauthor=J.+C.+Suttonauthor=C.+Kwonauthor=G.+Zhaoauthor=D.+R.+Magninauthor=D.+J.+Augeriauthor=T.+Gungorauthor=D.+P.+Rotellaauthor=Z.+Sunauthor=Y.+Liuauthor=W.+S.+Slusarchykauthor=J.+Marcinkevicieneauthor=J.+G.+Robertsonauthor=A.+Wangauthor=J.+A.+Roblauthor=K.+S.+Atwalauthor=R.+L.+Zahlerauthor=R.+A.+Parkerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Potent+non-nitrile+dipeptidic+dipeptidyl+peptidase+IV+inhibitors&doi=10.1016%2Fj.bmcl.2007.09.090"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.090%26sid%3Dliteratum%253Aachs%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DBolton%26aufirst%3DS.%26aulast%3DPi%26aufirst%3DZ.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DKwon%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DGungor%26aufirst%3DT.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BS.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DZahler%26aufirst%3DR.%2BL.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DPotent%2520non-nitrile%2520dipeptidic%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6476%26epage%3D6480%26doi%3D10.1016%2Fj.bmcl.2007.09.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':[],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Moritz Balkenhohl, Sebastian Kölbl, Tony Georgiev, <span class="NLM_string-name hlFld-ContribAuthor">Erick M. Carreira</span>. </span><span class="cited-content_cbyCitation_article-title">Mn- and Co-Catalyzed Aminocyclizations of Unsaturated Hydrazones Providing a Broad Range of Functionalized Pyrazolines. </span><span class="cited-content_cbyCitation_journal-name">JACS Au</span><span> <strong>2021,</strong> <em>1 </em>
                                    (7)
                                     , 919-924. <a href="https://doi.org/10.1021/jacsau.1c00176" title="DOI URL">https://doi.org/10.1021/jacsau.1c00176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacsau.1c00176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacsau.1c00176%26sid%3Dliteratum%253Aachs%26jtitle%3DJACS%2520Au%26atitle%3DMn-%252Band%252BCo-Catalyzed%252BAminocyclizations%252Bof%252BUnsaturated%252BHydrazones%252BProviding%252Ba%252BBroad%252BRange%252Bof%252BFunctionalized%252BPyrazolines%26aulast%3DBalkenhohl%26aufirst%3DMoritz%26date%3D2021%26date%3D2021%26date%3D11062021%26volume%3D1%26issue%3D7%26spage%3D919%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ian S. Young, Eric M. Simmons, Michaël D. B. Fenster, Jason J. Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Kishta R. Katipally</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed C–O Coupling of a Sterically Hindered Secondary Alcohol with an Aryl Bromide and Significant Purity Upgrade in the API Step. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (5)
                                     , 585-594. <a href="https://doi.org/10.1021/acs.oprd.8b00022" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00022%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPalladium-Catalyzed%252BC%2525E2%252580%252593O%252BCoupling%252Bof%252Ba%252BSterically%252BHindered%252BSecondary%252BAlcohol%252Bwith%252Ban%252BAryl%252BBromide%252Band%252BSignificant%252BPurity%252BUpgrade%252Bin%252Bthe%252BAPI%252BStep%26aulast%3DYoung%26aufirst%3DIan%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22012018%26date%3D12042018%26date%3D29032018%26volume%3D22%26issue%3D5%26spage%3D585%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David P.  Rotella</span>. </span><span class="cited-content_cbyCitation_article-title">Heterocycles in drug discovery: Properties and preparation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 149-183. <a href="https://doi.org/10.1016/bs.aihch.2020.10.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2020.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2020.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2020.10.002%26sid%3Dliteratum%253Aachs%26atitle%3DHeterocycles%252Bin%252Bdrug%252Bdiscovery%25253A%252BProperties%252Band%252Bpreparation%26aulast%3DRotella%26aufirst%3DDavid%2BP.%26date%3D2021%26spage%3D149%26epage%3D183%26pub%3DElsevier%26atitle%3DApplications%252Bof%252BHeterocycles%252Bin%252Bthe%252BDesign%252Bof%252BDrugs%252Band%252BAgricultural%252BProducts%26date%3D2021%26volume%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  He</span>, <span class="hlFld-ContribAuthor ">Yong  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule GLP-1 secretagogs: challenges and recent advances. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (11)
                                     , 2023-2029. <a href="https://doi.org/10.1016/j.drudis.2020.08.003" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DSmall-molecule%252BGLP-1%252Bsecretagogs%25253A%252Bchallenges%252Band%252Brecent%252Badvances%26aulast%3DHe%26aufirst%3DJie%26date%3D2020%26volume%3D25%26issue%3D11%26spage%3D2023%26epage%3D2029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Bioisosteres. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 225-304. <a href="https://doi.org/10.1002/9781119607311.ch4" title="DOI URL">https://doi.org/10.1002/9781119607311.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DBioisosteres%26date%3D2020%26date%3D2020%26spage%3D225%26epage%3D304%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruth E.  Gimeno</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Briere</span>, <span class="hlFld-ContribAuthor ">Randy J.  Seeley</span>. </span><span class="cited-content_cbyCitation_article-title">Leveraging the Gut to Treat Metabolic Disease. </span><span class="cited-content_cbyCitation_journal-name">Cell Metabolism</span><span> <strong>2020,</strong> <em>31 </em>
                                    (4)
                                     , 679-698. <a href="https://doi.org/10.1016/j.cmet.2020.02.014" title="DOI URL">https://doi.org/10.1016/j.cmet.2020.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cmet.2020.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cmet.2020.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Metabolism%26atitle%3DLeveraging%252Bthe%252BGut%252Bto%252BTreat%252BMetabolic%252BDisease%26aulast%3DGimeno%26aufirst%3DRuth%2BE.%26date%3D2020%26volume%3D31%26issue%3D4%26spage%3D679%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Zhao</span>, <span class="hlFld-ContribAuthor ">Jennifer Yin Yee  Kwan</span>, <span class="hlFld-ContribAuthor ">Kenneth  Yip</span>, <span class="hlFld-ContribAuthor ">Peter P.  Liu</span>, <span class="hlFld-ContribAuthor ">Fei-Fei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting metabolic dysregulation for fibrosis therapy. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     , 57-75. <a href="https://doi.org/10.1038/s41573-019-0040-5" title="DOI URL">https://doi.org/10.1038/s41573-019-0040-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0040-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0040-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DTargeting%252Bmetabolic%252Bdysregulation%252Bfor%252Bfibrosis%252Btherapy%26aulast%3DZhao%26aufirst%3DXiao%26date%3D2020%26date%3D2019%26volume%3D19%26issue%3D1%26spage%3D57%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Ren</span>, <span class="hlFld-ContribAuthor ">Xuekun  Wang</span>, <span class="hlFld-ContribAuthor ">Zongtao  Zhou</span>, <span class="hlFld-ContribAuthor ">Lijun  Hu</span>, <span class="hlFld-ContribAuthor ">Liming  Deng</span>, <span class="hlFld-ContribAuthor ">Li  Guan</span>, <span class="hlFld-ContribAuthor ">Qianqian  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of HWL-088: A highly potent FFA1/GPR40 agonist bearing a phenoxyacetic acid scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103209. <a href="https://doi.org/10.1016/j.bioorg.2019.103209" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103209%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHWL-088%25253A%252BA%252Bhighly%252Bpotent%252BFFA1%25252FGPR40%252Bagonist%252Bbearing%252Ba%252Bphenoxyacetic%252Bacid%252Bscaffold%26aulast%3DLi%26aufirst%3DZheng%26date%3D2019%26volume%3D92%26spage%3D103209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Chunxia  Liu</span>, <span class="hlFld-ContribAuthor ">Jianyong  Yang</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhiwen  Ye</span>, <span class="hlFld-ContribAuthor ">Dazhi  Feng</span>, <span class="hlFld-ContribAuthor ">Na  Yue</span>, <span class="hlFld-ContribAuthor ">Jiayi  Tong</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 608-622. <a href="https://doi.org/10.1016/j.ejmech.2019.06.087" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.087%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252BFFA1%25252FGPR40%252Bagonists%25253A%252BNew%252Bbreakthrough%252Bin%252Ban%252Bold%252Bscaffold%26aulast%3DLi%26aufirst%3DZheng%26date%3D2019%26volume%3D179%26spage%3D608%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of dihydropyrazole and pyrrolidine GPR40 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Dihydropyrazole D-Ring Analogues: (A) Synthesis of Dihydropyrazole A–B Ring and (B) Synthesis of D-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TFAA, DCM, 0 °C to rt, 81%; (b) benzenesulfonyl chloride, DIEA, DCM, 0 °C to rt, 90%; (c) Ag<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 65 °C, 46%; (d) NaBH<sub>4</sub>, THF/H<sub>2</sub>O, rt, 94%; (e) MsCl, Et<sub>3</sub>N, DCM, rt, 98%; (f) KCN, DMSO, 40 °C, 92%; (g) HCl (3.6 M in MeOH), rt, 82%; (h) Pd(dppf)Cl<sub>2</sub>, bis(pinacolato)diboron, KOAc, DMF, 80 °C, 90%; (i) 30% aq H<sub>2</sub>O<sub>2</sub>, EtOAc, rt, 85%; (j) ArBr, first-generation S-Phos precatalyst, LiHMDS, THF, 60 °C, 30–70%; (k) TsCl, pyridine, DMAP, rt, DCM, 55–80%; (l) <b>14</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 30–60%; (m) LiOH, H<sub>2</sub>O, THF, rt, 70–95%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of C-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) L-Selectride, THF, −78 °C, 88–98%; (b) TBS-OTf, Et<sub>3</sub>N, DCM, 0 °C to rt, 76–92%; (c) H<sub>2</sub> (1 atm), Pd/C, MeOH, rt, 97–100%; (d) K<sub>2</sub>CO<sub>3</sub>, 100 °C, DMSO, TBAF, THF, rt; followed by chiral separation, 30–32%; (e) Bu<sub>3</sub>P, ADDP, toluene, rt, <b>14</b>, 54–64%; (f) LiOH, H<sub>2</sub>O, THF, rt, 78–80%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Formation of oxidation metabolites and related GSH conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0015.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Glucose-lowering effects of compound <b>4</b> in mice during an intraperitoneal glucose tolerance test (IPGTT).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/medium/jm-2017-00982v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Plasma glucose levels of compound <b>4</b> in mice during an oral glucose tolerance test (OGTT). (b) Plasma active GLP-1 levels of compound <b>4</b> in mice during an OGTT. (c) Plasma insulin levels of compound <b>4</b> in mice during an OGTT.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b00982/20180201/images/large/jm-2017-00982v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00982&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Rotenstein, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozak, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shivers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarchoan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Close, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Close, K. L.</span><span> </span><span class="NLM_article-title">The ideal diabetes therapy: what will it look like? how close are we?</span> <span class="citation_source-journal">Clinical Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.2337/diaclin.30.2.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.2337%2Fdiaclin.30.2.44" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=44-53&author=L.+S.+Rotensteinauthor=B.+M.+Kozakauthor=J.+P.+Shiversauthor=M.+Yarchoanauthor=J.+Closeauthor=K.+L.+Close&title=The+ideal+diabetes+therapy%3A+what+will+it+look+like%3F+how+close+are+we%3F&doi=10.2337%2Fdiaclin.30.2.44"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2337%2Fdiaclin.30.2.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiaclin.30.2.44%26sid%3Dliteratum%253Aachs%26aulast%3DRotenstein%26aufirst%3DL.%2BS.%26aulast%3DKozak%26aufirst%3DB.%2BM.%26aulast%3DShivers%26aufirst%3DJ.%2BP.%26aulast%3DYarchoan%26aufirst%3DM.%26aulast%3DClose%26aufirst%3DJ.%26aulast%3DClose%26aufirst%3DK.%2BL.%26atitle%3DThe%2520ideal%2520diabetes%2520therapy%253A%2520what%2520will%2520it%2520look%2520like%253F%2520how%2520close%2520are%2520we%253F%26jtitle%3DClinical%2520Diabetes%26date%3D2012%26volume%3D30%26spage%3D44%26epage%3D53%26doi%3D10.2337%2Fdiaclin.30.2.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span> </span><span class="NLM_article-title">World health organization diabetes fact sheet 2013</span>, <a href="http://www.who.int/mediacentre/factsheets/fs312/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs312/en/</a> (accessed on Feb 29, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+health+organization+diabetes+fact+sheet+2013%2C+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs312%2Fen%2F+%28accessed+on+Feb+29%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DWorld%2520health%2520organization%2520diabetes%2520fact%2520sheet%25202013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">International diabetes federation</span>. <span> </span><span class="NLM_article-title">Diabetes Atlas</span>, 8th ed., 2017, <a href="http://www.diabetesatlas.org/resources/2017-atlas.html" class="extLink">http://www.diabetesatlas.org/resources/2017-atlas.html</a> (accessed Dec 11, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=International+diabetes+federation.+Diabetes+Atlas%2C+8th+ed.%2C+2017%2C+http%3A%2F%2Fwww.diabetesatlas.org%2Fresources%2F2017-atlas.html+%28accessed+Dec+11%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DDiabetes%2520Atlas" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span> </span><span class="NLM_article-title">Standards of medical care in diabetes—2015: summary of revisions</span>.  <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>),  <span class="NLM_fpage">S4</span>.<span class="refDoi"> DOI: 10.2337/dc15-S003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.2337%2Fdc15-S003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Standards+of+medical+care+in+diabetes%E2%80%942015%3A+summary+of+revisions.+Diabetes+Care+2015%2C+38+%28Suppl.+1%29%2C+S4.+10.2337%2Fdc15-S003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2337%2Fdc15-S003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdc15-S003%26sid%3Dliteratum%253Aachs%26atitle%3DStandards%2520of%2520medical%2520care%2520in%2520diabetes%25E2%2580%25942015%253A%2520summary%2520of%2520revisions%26jtitle%3DDiabetes%2520Care%26date%3D2015%26volume%3D38%26issue%3DSuppl.%25201%26spage%3DS4%26doi%3D10.2337%2Fdc15-S003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilsboll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">The incretin system and its role in type 2 diabetes mellitus</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.mce.2008.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.mce.2008.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=18786605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=127-136&author=J.+J.+Holstauthor=T.+Vilsbollauthor=C.+F.+Deacon&title=The+incretin+system+and+its+role+in+type+2+diabetes+mellitus&doi=10.1016%2Fj.mce.2008.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The incretin system and its role in type 2 diabetes mellitus</span></div><div class="casAuthors">Holst, Jens Juul; Vilsboell, Tina; Deacon, Carolyn F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The incretin hormones are released during meals from gut endocrine cells.  They potentiate glucose-induced insulin secretion and may be responsible for up to 70% of postprandial insulin secretion.  The incretin hormones include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), both of which may also promote proliferation/neogenesis of beta cells and prevent their decay (apoptosis).  Both hormones contribute to insulin secretion from the beginning of a meal and their effects are progressively amplified as plasma glucose concns. rise.  The current interest in the incretin hormones is due to the fact that the incretin effect is severely reduced or absent in patients with type 2 diabetes mellitus (T2DM).  In addn., there is hyperglucagonemia, which is not suppressible by glucose.  In such patients, the secretion of GIP is near normal, but its effect on insulin secretion, particularly the late phase, is severely impaired.  The loss of GIP action is probably a consequence of diabetes, since it is also obsd. in patients with diabetes secondary to chronic pancreatitis, in whom the incretin effect is also lost.  GLP-1 secretion, on the other hand, is also impaired, but its insulinotropic and glucagon-suppressive actions are preserved, although the potency of GLP-1 in this respect is decreased compared to healthy subjects.  However, in supraphysiol. doses, GLP-1 administration may completely normalize beta as well as alpha cell sensitivity to glucose.  The impaired action of GLP-1 and GIP in T2DM may be at least partly restored by improved glycemic control, as shown in studies involving 4 wk of intensive insulin therapy.  The reduced incretin effect is believed to contribute to impaired regulation of insulin and glucagon secretion in T2DM, and, in support of this, exogenous GLP-1 administration may restore blood glucose regulation to near normal levels.  Thus, the pathogenesis of T2DM seems to involve a dysfunction of both incretins.  Enhancement of incretin action may therefore represent a therapeutic soln.  Clin. strategies therefore include the development of metabolically stable activators of the GLP-1 receptor; and inhibition of DPP-4, the enzyme that destroys native GLP-1 almost immediately.  Orally active DPP-4 inhibitors and the metabolically stable activators, exenatide (Byetta), are now on the market, and numerous clin. studies have shown that both principles are assocd. with durable antidiabetic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEt5VBmX7VnLVg90H21EOLACvtfcHk0lhSobByBy9xIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajt73P&md5=5995635fd35fb982d0b8740353f86dc3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2008.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2008.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DVilsboll%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DThe%2520incretin%2520system%2520and%2520its%2520role%2520in%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2009%26volume%3D297%26spage%3D127%26epage%3D136%26doi%3D10.1016%2Fj.mce.2008.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Campbell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drucker, D. J.</span><span> </span><span class="NLM_article-title">Pharmacology, physiology, and mechanisms of incretin hormone action</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.1016/j.cmet.2013.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.cmet.2013.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=23684623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=819-837&author=J.+E.+Campbellauthor=D.+J.+Drucker&title=Pharmacology%2C+physiology%2C+and+mechanisms+of+incretin+hormone+action&doi=10.1016%2Fj.cmet.2013.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action</span></div><div class="casAuthors">Campbell, Jonathan E.; Drucker, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">819-837</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Incretin peptides, principally GLP-1 and GIP, regulate islet hormone secretion, glucose concns., lipid metab., gut motility, appetite and body wt., and immune function, providing a scientific basis for utilizing incretin-based therapies in the treatment of type 2 diabetes.  Activation of GLP-1 and GIP receptors also leads to nonglycemic effects in multiple tissues, through direct actions on tissues expressing incretin receptors and indirect mechanisms mediated through neuronal and endocrine pathways.  Here we contrast the pharmacol. and physiol. of incretin hormones and review recent advances in mechanisms coupling incretin receptor signaling to pleiotropic metabolic actions in preclin. studies.  We discuss whether mechanisms identified in preclin. studies have potential translational relevance for the treatment of human disease and highlight controversies and uncertainties in incretin biol. that require resoln. in future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRNiGuKdmu97Vg90H21EOLACvtfcHk0lhSobByBy9xIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGktbs%253D&md5=8a82721ed5d7542784f27ca95c62a694</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2013.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2013.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DJ.%2BE.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DPharmacology%252C%2520physiology%252C%2520and%2520mechanisms%2520of%2520incretin%2520hormone%2520action%26jtitle%3DCell%2520Metab.%26date%3D2013%26volume%3D17%26spage%3D819%26epage%3D837%26doi%3D10.1016%2Fj.cmet.2013.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">U.S. Food and Drug Administration</span>. <span> </span><span class="NLM_article-title">Guidance for Industry Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention</span>, Appendix A, <a href="https://www.fda.gov/downloads/Drugs/.../Guidances/ucm071624.pdf" class="extLink">https://www.fda.gov/downloads/Drugs/.../Guidances/ucm071624.pdf</a> (accessed Aug 14, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+Food+and+Drug+Administration.+Guidance+for+Industry+Diabetes+Mellitus%3A+Developing+Drugs+and+Therapeutic+Biologics+for+Treatment+and+Prevention%2C+Appendix+A%2C+https%3A%2F%2Fwww.fda.gov%2Fdownloads%2FDrugs%2F...%2FGuidances%2Fucm071624.pdf+%28accessed+Aug+14%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DGuidance%2520for%2520Industry%2520Diabetes%2520Mellitus%253A%2520Developing%2520Drugs%2520and%2520Therapeutic%2520Biologics%2520for%2520Treatment%2520and%2520Prevention" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Khan, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L.</span><span> </span><span class="NLM_article-title">The role of polyunsaturated fatty acids and GPR40 receptor in brain</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.neuropharm.2015.05.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=639-651&author=M.+Z.+Khanauthor=L.+He&title=The+role+of+polyunsaturated+fatty+acids+and+GPR40+receptor+in+brain&doi=10.1016%2Fj.neuropharm.2015.05.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BZ.%26aulast%3DHe%26aufirst%3DL.%26atitle%3DThe%2520role%2520of%2520polyunsaturated%2520fatty%2520acids%2520and%2520GPR40%2520receptor%2520in%2520brain%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D113%26spage%3D639%26epage%3D651%26doi%3D10.1016%2Fj.neuropharm.2015.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, Y. Q.</span><span> </span><span class="NLM_article-title">GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5603</span><span class="NLM_x">–</span> <span class="NLM_lpage">5612</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.bmcl.2016.10.074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5603-5612&author=C.+Chenauthor=H.+Liauthor=Y.+Q.+Long&title=GPR40+agonists+for+the+treatment+of+type+2+diabetes+mellitus%3A+The+biological+characteristics+and+the+chemical+space&doi=10.1016%2Fj.bmcl.2016.10.074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.074%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLong%26aufirst%3DY.%2BQ.%26atitle%3DGPR40%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%253A%2520The%2520biological%2520characteristics%2520and%2520the%2520chemical%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5603%26epage%3D5612%26doi%3D10.1016%2Fj.bmcl.2016.10.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hara, T.</span><span> </span><span class="NLM_article-title">Ligands at Free Fatty Acid Receptor 1 (GPR40)</span>. In  <span class="citation_source-book">Handbook of Experimental Pharmacology</span>; <span class="NLM_contrib-group">Milligan, G.; Kimura, I.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1007%2F164_2016_59" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=1-16&author=T.+Haraauthor=G.+Milligan&author=I.+Kimura&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F164_2016_59&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F164_2016_59%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DT.%26atitle%3DLigands%2520at%2520Free%2520Fatty%2520Acid%2520Receptor%25201%2520%2528GPR40%2529%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DMilligan%26aufirst%3DG.%26pub%3DSpringer%26date%3D2016%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Morgan, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhayal, S.</span><span> </span><span class="NLM_article-title">G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span><span class="refDoi"> DOI: 10.1016/j.bcp.2009.07.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.bcp.2009.07.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=1419-1427&author=N.+G.+Morganauthor=S.+Dhayal&title=G-protein+coupled+receptors+mediating+long+chain+fatty+acid+signalling+in+the+pancreatic+beta-cell&doi=10.1016%2Fj.bcp.2009.07.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.07.020%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DN.%2BG.%26aulast%3DDhayal%26aufirst%3DS.%26atitle%3DG-protein%2520coupled%2520receptors%2520mediating%2520long%2520chain%2520fatty%2520acid%2520signalling%2520in%2520the%2520pancreatic%2520beta-cell%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D1419%26epage%3D1427%26doi%3D10.1016%2Fj.bcp.2009.07.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Edfalk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steneberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, H.</span><span> </span><span class="NLM_article-title">GPR40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2280</span><span class="NLM_x">–</span> <span class="NLM_lpage">2287</span><span class="refDoi"> DOI: 10.2337/db08-0307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.2337%2Fdb08-0307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=18519800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=2280-2287&author=S.+Edfalkauthor=P.+Stenebergauthor=H.+Edlund&title=GPR40+is+expressed+in+enteroendocrine+cells+and+mediates+free+fatty+acid+stimulation+of+incretin+secretion&doi=10.2337%2Fdb08-0307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion</span></div><div class="casAuthors">Edfalk, Sara; Steneberg, Paer; Edlund, Helena</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2280-2287</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Objective-The G-protein-coupled receptor Gpr40 is expressed in β-cells where it contributes to free fatty acid (FFA) enhancement of glucose-stimulated insulin secretion.  However, other sites of Gpr40 expression, including the intestine, have been suggested.  The transcription factor IPF1/PDX1 was recently shown to bind to an enhancer element within the 5'-flanking region of Gpr40, implying that IPF1/PDX1 might regulate Gpr40 expression.  Here, we addressed whether (1) Gpr40 is expressed in the intestine and (2) Ipf1/Pdx1 function is required for Gpr40 expression.  Research Design and Methods-In the present study, Gpr40 expression was monitored by X-gal staining using Gpr40 reporter mice and by in situ hybridization.  Ipf1/Pdx1-null and β-cell specific mutants were used to investigate whether Ipf1/Pdx1 controls Gpr40 expression.  Plasma insulin, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucose levels in response to acute oral fat diet were detd. in Gpr40 mutant and control mice.  Results-Here, we show that Gpr40 is expressed in endocrine cells of the gastrointestinal tract, including cells expressing the incretin hormones GLP-1 and GIP, and that Gpr40 mediates FFA-stimulated incretin secretion.  We also show that Ipf1/Pdx1 is required for expression of Gpr40 in β-cells and endocrine cells of the anterior gastrointestinal tract.  Conclusions-Together, our data provide evidence that Gpr40 modulates FFA-stimulated insulin secretion from β-cells not only directly but also indirectly via regulation of incretin secretion.  Moreover, our data suggest a conserved role for Ipf1/Pdx1 and Gpr40 in FFA-mediated secretion of hormones that regulate glucose and overall energy homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAqbrs6Tw1bVg90H21EOLACvtfcHk0liXaP0mmew1gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrtrvP&md5=5263b80283b86beb0eba5c41d1c25bb0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2337%2Fdb08-0307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb08-0307%26sid%3Dliteratum%253Aachs%26aulast%3DEdfalk%26aufirst%3DS.%26aulast%3DSteneberg%26aufirst%3DP.%26aulast%3DEdlund%26aufirst%3DH.%26atitle%3DGPR40%2520is%2520expressed%2520in%2520enteroendocrine%2520cells%2520and%2520mediates%2520free%2520fatty%2520acid%2520stimulation%2520of%2520incretin%2520secretion%26jtitle%3DDiabetes%26date%3D2008%26volume%3D57%26spage%3D2280%26epage%3D2287%26doi%3D10.2337%2Fdb08-0307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hauge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestmar, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husted, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Salvo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinglass, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelstoft, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luckmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo</span> <span class="citation_source-journal">Mol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1016/j.molmet.2014.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.molmet.2014.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=25685685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCku7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=3-14&author=M.+Haugeauthor=M.+A.+Vestmarauthor=A.+S.+Hustedauthor=J.+P.+Ekbergauthor=M.+J.+Wrightauthor=J.+Di+Salvoauthor=A.+B.+Weinglassauthor=M.+S.+Engelstoftauthor=A.+N.+Madsenauthor=M.+Luckmannauthor=M.+W.+Millerauthor=M.+E.+Trujilloauthor=T.+M.+Frimurerauthor=B.+Holstauthor=A.+D.+Howardauthor=T.+W.+Schwartz&title=GPR40+%28FFAR1%29+-+Combined+Gs+and+Gq+signaling+in+vitro+is+associated+with+robust+incretin+secretagogue+action+ex+vivo+and+in+vivo&doi=10.1016%2Fj.molmet.2014.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo</span></div><div class="casAuthors">Hauge, Maria; Vestmar, Marie A.; Husted, Anna S.; Ekberg, Jeppe P.; Wright, Michael J.; Di Salvo, Jerry; Weinglass, Adam B.; Engelstoft, Maja S.; Madsen, Andreas N.; Luckmann, Michael; Miller, Michael W.; Trujillo, Maria E.; Frimurer, Thomas M.; Holst, Birgitte; Howard, Andrew D.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-14</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">GPR40 (FFAR1), a clin. proven anti-diabetes target, is a Gq-coupled receptor for long chain fatty acids (LCFA) stimulating insulin secretion directly and mediating a major part of the dietary triglyceride-induced secretion of the incretins GLP-1 and GIP.  In phase-II studies the GPR40 agonist TAK-875 decreased blood glucose but surprisingly without stimulating incretins.  Here we find that GPR40 can signal through not only Gq and IP3 but also Gs and cAMP when stimulated with certain agonists such as AM-1638 and AM-5262 in contrast to the endogenous LCFA ligands and agonists such as TAK-875 and AM-837, which only signal through Gq.  In competition binding against [3H]AM-1638 and [3H]L358 the Gq + Gs and the Gq-only agonists either competed for or showed pos. cooperativity by increasing the binding of the two different radio-ligands, in opposite ways.  Nevertheless, both the Gq-only and the Gq + Gs agonists all docked surprisingly well into the binding site for TAK-875 in the X-ray structure of GPR40.  In murine intestinal primary cell-cultures the endogenous LCFAs and the Gq-only agonists stimulated GLP-1 secretion with rather poor efficacy as compared with the high efficacy Gq + Gs GPR40 agonists and a prototype GPR119 agonist.  Similarly, in fasting both male and female mice the Gq + Gs agonists showed significantly higher efficacy than the Gq-only agonists in respect of increasing plasma GLP-1 and plasma GIP in a GPR40-dependent manner.  It is concluded that stimulation of GPR40 by endogenous LCFAs or by Gq-only synthetic agonists result in a rather limited incretin response, whereas Gq + Gs GPR40 agonists stimulate incretin secretion robustly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZyjcjTNd0QbVg90H21EOLACvtfcHk0ljkNXXB6CuouA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCku7bN&md5=895136bef8c9542711e6daf5fa57219c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2014.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DHauge%26aufirst%3DM.%26aulast%3DVestmar%26aufirst%3DM.%2BA.%26aulast%3DHusted%26aufirst%3DA.%2BS.%26aulast%3DEkberg%26aufirst%3DJ.%2BP.%26aulast%3DWright%26aufirst%3DM.%2BJ.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DWeinglass%26aufirst%3DA.%2BB.%26aulast%3DEngelstoft%26aufirst%3DM.%2BS.%26aulast%3DMadsen%26aufirst%3DA.%2BN.%26aulast%3DLuckmann%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DM.%2BW.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DGPR40%2520%2528FFAR1%2529%2520-%2520Combined%2520Gs%2520and%2520Gq%2520signaling%2520in%2520vitro%2520is%2520associated%2520with%2520robust%2520incretin%2520secretagogue%2520action%2520ex%2520vivo%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Metab.%26date%3D2015%26volume%3D4%26spage%3D3%26epage%3D14%26doi%3D10.1016%2Fj.molmet.2014.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toteva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C. H.</span><span> </span><span class="NLM_article-title">A potent class of GPR40 full agonists engages the enteroInsular axis to promote glucose control in rodents</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e463000</span><span class="NLM_x">–</span> <span class="NLM_lpage">e463012</span><span class="refDoi"> DOI: 10.1371/journal.pone.0046300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1371%2Fjournal.pone.0046300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e463000-e463012&author=J.+Luoauthor=G.+Swaminathauthor=S.+P.+Brownauthor=J.+Zhangauthor=Q.+Guoauthor=M.+Chenauthor=K.+Nguyenauthor=T.+Tranauthor=L.+Miaoauthor=P.+Dransfieldauthor=M.+Vimolratanaauthor=J.+Houzeauthor=S.+Wongauthor=M.+Totevaauthor=B.+Shanauthor=F.+Liauthor=R.+Zhuangauthor=D.+C.+H.+Lin&title=A+potent+class+of+GPR40+full+agonists+engages+the+enteroInsular+axis+to+promote+glucose+control+in+rodents&doi=10.1371%2Fjournal.pone.0046300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0046300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0046300%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DDransfield%26aufirst%3DP.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DHouze%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DToteva%26aufirst%3DM.%26aulast%3DShan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.%2BH.%26atitle%3DA%2520potent%2520class%2520of%2520GPR40%2520full%2520agonists%2520engages%2520the%2520enteroInsular%2520axis%2520to%2520promote%2520glucose%2520control%2520in%2520rodents%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De463000%26epage%3De463012%26doi%3D10.1371%2Fjournal.pone.0046300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Brown, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimolratana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiao, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattaropong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminath, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houze, B.</span><span> </span><span class="NLM_article-title">J. Discovery of AM-1638: a potent and orally bioavailable GPR40/FFA1 full agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1021/ml300133f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300133f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=726-730&author=S.+P.+Brownauthor=P.+J.+Dransfieldauthor=M.+Vimolratanaauthor=X.+Y.+Jiaoauthor=L.+Zhuauthor=V.+Pattaropongauthor=Y.+Sunauthor=J.+Liuauthor=J.+Luoauthor=J.+Zhangauthor=S.+Wongauthor=R.+Zhuangauthor=Q.+Guoauthor=F.+Liauthor=J.+C.+Medinaauthor=G.+Swaminathauthor=D.+C.-H.+Linauthor=B.+Houze&title=J.+Discovery+of+AM-1638%3A+a+potent+and+orally+bioavailable+GPR40%2FFFA1+full+agonist&doi=10.1021%2Fml300133f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fml300133f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300133f%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BP.%26aulast%3DDransfield%26aufirst%3DP.%2BJ.%26aulast%3DVimolratana%26aufirst%3DM.%26aulast%3DJiao%26aufirst%3DX.%2BY.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DZhuang%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DSwaminath%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%2BC.-H.%26aulast%3DHouze%26aufirst%3DB.%26atitle%3DJ.%2520Discovery%2520of%2520AM-1638%253A%2520a%2520potent%2520and%2520orally%2520bioavailable%2520GPR40%252FFFA1%2520full%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D726%26epage%3D730%26doi%3D10.1021%2Fml300133f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jurica, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nirschl, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampulla, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunselman, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnur, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierks, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvijic, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panemangalore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whaley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewing, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, B. A.</span><span> </span><span class="NLM_article-title">Discovery of pyrrolidine-containing GPR40 agonists: stereochemistry effects a change in binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1431</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01559</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01559" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1417-1431&author=E.+A.+Juricaauthor=X.+Wuauthor=K.+N.+Williamsauthor=A.+S.+Hernandezauthor=D.+S.+Nirschlauthor=R.+A.+Rampullaauthor=A.+Mathurauthor=M.+Zhouauthor=G.+Caoauthor=C.+Xieauthor=B.+Jacobauthor=H.+Caiauthor=T.+Wangauthor=B.+J.+Murphyauthor=H.+Liuauthor=C.+Xuauthor=L.+K.+Kunselmanauthor=M.+B.+Hicksauthor=Q.+Sunauthor=D.+M.+Schnurauthor=E.+A.+Dierksauthor=A.+Apedoauthor=D.+B.+Mooreauthor=K.+A.+Fosterauthor=M.+E.+Cvijicauthor=R.+Panemangaloreauthor=N.+A.+Flynnauthor=B.+D.+Maxwellauthor=Y.+Hongauthor=Y.+Tianauthor=J.+J.+Wilkesauthor=B.+A.+Zinkerauthor=J.+M.+Whaleyauthor=J.+C.+Barrishauthor=J.+A.+Roblauthor=W.+R.+Ewingauthor=B.+A.+Ellsworth&title=Discovery+of+pyrrolidine-containing+GPR40+agonists%3A+stereochemistry+effects+a+change+in+binding+mode&doi=10.1021%2Facs.jmedchem.6b01559"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01559%26sid%3Dliteratum%253Aachs%26aulast%3DJurica%26aufirst%3DE.%2BA.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWilliams%26aufirst%3DK.%2BN.%26aulast%3DHernandez%26aufirst%3DA.%2BS.%26aulast%3DNirschl%26aufirst%3DD.%2BS.%26aulast%3DRampulla%26aufirst%3DR.%2BA.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DJacob%26aufirst%3DB.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DB.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DKunselman%26aufirst%3DL.%2BK.%26aulast%3DHicks%26aufirst%3DM.%2BB.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DSchnur%26aufirst%3DD.%2BM.%26aulast%3DDierks%26aufirst%3DE.%2BA.%26aulast%3DApedo%26aufirst%3DA.%26aulast%3DMoore%26aufirst%3DD.%2BB.%26aulast%3DFoster%26aufirst%3DK.%2BA.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DPanemangalore%26aufirst%3DR.%26aulast%3DFlynn%26aufirst%3DN.%2BA.%26aulast%3DMaxwell%26aufirst%3DB.%2BD.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DWilkes%26aufirst%3DJ.%2BJ.%26aulast%3DZinker%26aufirst%3DB.%2BA.%26aulast%3DWhaley%26aufirst%3DJ.%2BM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520of%2520pyrrolidine-containing%2520GPR40%2520agonists%253A%2520stereochemistry%2520effects%2520a%2520change%2520in%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1417%26epage%3D1431%26doi%3D10.1021%2Facs.jmedchem.6b01559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ellsworth, B. A.; Shi, J.; Jurica, E. A.; Nielsen, L. L.; Wu, X.; Hernandez, A. S.; Wang, Y.; Gu, Z.; Williams, K. N.; Chen, B.; Cherney, E. C.; Ye, X.-Y.; Wang, Y.; Zhou, M.; Cao, G.; Xie, C.; Wilkes, J. J.; Liu, H.; Kunselman, L. K.; Gupta, A. K.; Jayarama, R.; Ramar, T.; Rao, P.; Zinker, B. A.; Sun, Q.; Dierks, E. A.; Foster, K. A.; Wang, T.; Cviji, M. E.; Whaley, J. M.; Robl, J. A.; Ewing, W. R.</span><span> </span><span class="NLM_article-title">Discovery of BMS-986118, a dual MOA GPR40 agonist that produces glucose-dependent insulin and GLP-1 secretion</span>. Presented at the 248th ACS National Meeting, San Francisco, CA, Aug 10–14,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>MEDI031.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+A.+Ellsworth&author=J.+Shi&author=E.+A.+Jurica&author=L.+L.+Nielsen&author=X.+Wu&author=A.+S.+Hernandez&author=Y.+Wang&author=Z.+Gu&author=K.+N.+Williams&author=B.+Chen&author=E.+C.+Cherney&author=X.-Y.+Ye&author=Y.+Wang&author=M.+Zhou&author=G.+Cao&author=C.+Xie&author=J.+J.+Wilkes&author=H.+Liu&author=L.+K.+Kunselman&author=A.+K.+Gupta&author=R.+Jayarama&author=T.+Ramar&author=P.+Rao&author=B.+A.+Zinker&author=Q.+Sun&author=E.+A.+Dierks&author=K.+A.+Foster&author=T.+Wang&author=M.+E.+Cviji&author=J.+M.+Whaley&author=J.+A.+Robl&author=W.+R.+Ewing&title=Discovery+of+BMS-986118%2C+a+dual+MOA+GPR40+agonist+that+produces+glucose-dependent+insulin+and+GLP-1+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DEllsworth%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520of%2520BMS-986118%252C%2520a%2520dual%2520MOA%2520GPR40%2520agonist%2520that%2520produces%2520glucose-dependent%2520insulin%2520and%2520GLP-1%2520secretion%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">Compound <b>1</b> produced an increase in locomotor activity at a dose of 80 mg/kg (plasma concentration, Cmax = 333 uM) in a study in telemeterized mice. Compound <b>2</b> produced a increase of heart rate by 20 bpm a study of telemeterized cynomologous monkeys at a dose of 180 mg/kg (plasma concentration, <i>C</i><sub>max</sub> = 33–39 μM).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span> </span><span class="NLM_article-title">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span><span class="refDoi"> DOI: 10.1517/17425250903042318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1517%2F17425250903042318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=19519283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=921-931&author=D.+A.+Priceauthor=J.+Blaggauthor=L.+Jonesauthor=N.+Greeneauthor=T.+Wager&title=Physicochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes%3A+a+review&doi=10.1517%2F17425250903042318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span></div><div class="casAuthors">Price, David A.; Blagg, Julian; Jones, Lyn; Greene, Nigel; Wager, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-931</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The genesis of any toxicol. or safety outcome is multifactorial and complex; for this reason, it can be difficult for drug discovery projects to factor the avoidance of toxicity outcomes into their target design.  A focus on readily measurable parameters from high-throughput in vitro assays (e.g., primary potency, clearance) is easier to handle and have become the mainstays of drug discovery projects.  However, the fundamental origins of adverse safety or toxicity findings can be considered as deriving from four parameters, all of which are in the control of the drug designer.  These can be described as primary pharmacol., off target pharmacol., the presence of a defined structural fragment that can be assocd. with adverse outcomes and the overall physicochem. properties of the mol. that may predispose it to adverse outcomes.  In the drug discovery community, there has been recognition for many years of the influence of physicochem. drug properties (in particular lipophilicity) on the toxicol. profile of compds., and recent research is now beginning to quantify that risk in a probabilistic sense.  This review focuses on the overall properties of classes of mols. that are assocd. with an increased probability of adverse outcomes in in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8kwwUsaFIrVg90H21EOLACvtfcHk0lhznnXwl04Qng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D&md5=bd1cca3634afda14de2f8aa115d7d55e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F17425250903042318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903042318%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DWager%26aufirst%3DT.%26atitle%3DPhysicochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%253A%2520a%2520review%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D921%26epage%3D931%26doi%3D10.1517%2F17425250903042318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span><span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhznnXwl04Qng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Garanti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilati, T.</span><span> </span><span class="NLM_article-title">Diastereoselective cycloadditions of nitrilimines to enantiopure acrylamides</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span><span class="refDoi"> DOI: 10.1016/S0957-4166(02)00258-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2FS0957-4166%2802%2900258-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=1285-1289&author=L.+Garantiauthor=G.+Molteniauthor=T.+Pilati&title=Diastereoselective+cycloadditions+of+nitrilimines+to+enantiopure+acrylamides&doi=10.1016%2FS0957-4166%2802%2900258-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2802%2900258-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252802%252900258-6%26sid%3Dliteratum%253Aachs%26aulast%3DGaranti%26aufirst%3DL.%26aulast%3DMolteni%26aufirst%3DG.%26aulast%3DPilati%26aufirst%3DT.%26atitle%3DDiastereoselective%2520cycloadditions%2520of%2520nitrilimines%2520to%2520enantiopure%2520acrylamides%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2002%26volume%3D13%26spage%3D1285%26epage%3D1289%26doi%3D10.1016%2FS0957-4166%2802%2900258-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaura, N.</span><span> </span><span class="NLM_article-title">Palladium(0)-catalyzed cross-coupling reaction of alkoxydiboron with haloarenes: a direct procedure for arylboronic esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7508</span><span class="NLM_x">–</span> <span class="NLM_lpage">7510</span><span class="refDoi"> DOI: 10.1021/jo00128a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-catalyzed+cross-coupling+reaction+of+alkoxydiboron+with+haloarenes%3A+a+direct+procedure+for+arylboronic+esters&doi=10.1021%2Fjo00128a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0lhb9bNm_WUfvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520cross-coupling%2520reaction%2520of%2520alkoxydiboron%2520with%2520haloarenes%253A%2520a%2520direct%2520procedure%2520for%2520arylboronic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510%26doi%3D10.1021%2Fjo00128a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Uetrecht, J.</span><span> </span><span class="NLM_article-title">Idiosyncratic drug reactions: past, present, and future</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1021/tx700186p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700186p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlygsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=84-92&author=J.+Uetrecht&title=Idiosyncratic+drug+reactions%3A+past%2C+present%2C+and+future&doi=10.1021%2Ftx700186p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Idiosyncratic Drug Reactions: Past, Present, and Future</span></div><div class="casAuthors">Uetrecht, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-92</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although the major working hypothesis for the mechanism of idiosyncratic drug reactions (IDRs), the hapten hypothesis, has not changed since 1987, several hypotheses have been added, for example, the danger hypothesis and the pharmaceutical interaction hypothesis.  Genetic studies have found that several IDRs are linked to specific HLA genes, providing addnl. evidence that they are immune-mediated.  Evidence that most IDRs are caused by reactive metabolites has led pharmaceutical companies to avoid drug candidates that form significant amts. of reactive metabolites; however, at least one IDR, ximelagatran-induced liver toxicity, does not appear to be caused by a reactive metabolite.  It is possible that there are biomarkers such as those related to cell stress that would predict that a drug candidate would cause a significant incidence of IDRs; however, there has been no systematic study of the changes in gene expression induced by drugs known to cause IDRs.  A major impediment to the study of the mechanisms of IDRs is the paucity of valid animal models, and if we had a better mechanistic understanding, it should be easier to develop such models.  There is growing evidence that these adverse reactions are more varied and complex than previously recognized, and it is unlikely that a quick fix will be achieved.  However, IDRs are an important cause of patient morbidity and mortality and markedly increase the uncertainty of drug development; therefore, continued basic research in this area is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLG5_bNuaw4LVg90H21EOLACvtfcHk0lhb9bNm_WUfvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlygsr%252FN&md5=eaed35d895118a05034c7762efd060dc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Ftx700186p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700186p%26sid%3Dliteratum%253Aachs%26aulast%3DUetrecht%26aufirst%3DJ.%26atitle%3DIdiosyncratic%2520drug%2520reactions%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D84%26epage%3D92%26doi%3D10.1021%2Ftx700186p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gungor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusarchyk, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6476</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;key=10.1016%2Fj.bmcl.2007.09.090" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6476-6480&author=L.+M.+Simpkinsauthor=S.+Boltonauthor=Z.+Piauthor=J.+C.+Suttonauthor=C.+Kwonauthor=G.+Zhaoauthor=D.+R.+Magninauthor=D.+J.+Augeriauthor=T.+Gungorauthor=D.+P.+Rotellaauthor=Z.+Sunauthor=Y.+Liuauthor=W.+S.+Slusarchykauthor=J.+Marcinkevicieneauthor=J.+G.+Robertsonauthor=A.+Wangauthor=J.+A.+Roblauthor=K.+S.+Atwalauthor=R.+L.+Zahlerauthor=R.+A.+Parkerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Potent+non-nitrile+dipeptidic+dipeptidyl+peptidase+IV+inhibitors&doi=10.1016%2Fj.bmcl.2007.09.090"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.090%26sid%3Dliteratum%253Aachs%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DBolton%26aufirst%3DS.%26aulast%3DPi%26aufirst%3DZ.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DKwon%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DGungor%26aufirst%3DT.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BS.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DZahler%26aufirst%3DR.%2BL.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DPotent%2520non-nitrile%2520dipeptidic%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6476%26epage%3D6480%26doi%3D10.1016%2Fj.bmcl.2007.09.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i48"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00982">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_76416"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00982">10.1021/acs.jmedchem.7b00982</a>. Full crystallographic data for compound <b>8</b> have been deposited to the Cambridge Crystallographic Data Center (CCDC reference no. 1559162) and can be obtained free of charge via the Internet at <a class="extLink" href="http://www.ccdc.cam.ac.uk">http://www.ccdc.cam.ac.uk</a>. <ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures for the synthesis of compounds <b>3b</b>–<b>35</b> and methods for <i>in vitro</i> and <i>in vivo</i> biological studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_001.pdf">PDF</a>)</p></li><li><p class="inline">X-ray crystallographic data for <b>8</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_002.cif">CIF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_001.pdf">jm7b00982_si_001.pdf (733.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_002.cif">jm7b00982_si_002.cif (21.48 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00982/suppl_file/jm7b00982_si_003.csv">jm7b00982_si_003.csv (4.02 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00982&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-3%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00982%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00982" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995d7bd8431969","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
